Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-139-3p SOX4 -2.53 0 0.75 0.00274 miRNATAP -0.34 0 NA
2 hsa-miR-204-5p SOX4 -0.54 0.03309 0.75 0.00274 miRNAWalker2 validate; miRNATAP -0.21 1.0E-5 26323722; 24984017 Upregulation of microRNA 204 inhibits cell proliferation migration and invasion in human renal cell carcinoma cells by downregulating SOX4;Decreased miR 204 in H pylori associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4; Luciferase assay revealed that SOX4 was target gene of miR-204 which was found up-regulated in H pylori positive tissues; Down-regulation of miR-204 and over-expression of SOX4 promoted epithelial-mesenchymal transition process; Taken together our findings demonstrated that miR-204 may act as a tumor suppressor in H pylori induced gastric cancer by targeting SOX4
3 hsa-miR-30e-3p SOX4 -1.21 0 0.75 0.00274 mirMAP -0.52 0 NA
4 hsa-miR-32-5p SOX4 0.08 0.54898 0.75 0.00274 MirTarget; miRNATAP -0.19 0.03899 NA
5 hsa-miR-34a-5p SOX4 1.04 0 0.75 0.00274 miRNATAP -0.19 0.03067 NA
6 hsa-miR-616-3p SOX4 -0.7 2.0E-5 0.75 0.00274 mirMAP -0.16 0.03454 NA
7 hsa-miR-616-5p SOX4 0.15 0.40284 0.75 0.00274 MirTarget; mirMAP; miRNATAP -0.23 0.00081 NA
8 hsa-miR-618 SOX4 0.14 0.51715 0.75 0.00274 PITA; miRNATAP -0.24 7.0E-5 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF CELL DEATH 429 1472 2.834e-81 1.117e-77
2 REGULATION OF CELL PROLIFERATION 433 1496 4.801e-81 1.117e-77
3 POSITIVE REGULATION OF RESPONSE TO STIMULUS 502 1929 3.952e-77 6.129e-74
4 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 485 1848 1.438e-75 1.673e-72
5 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 446 1656 1.058e-72 9.842e-70
6 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 443 1672 8.897e-70 6.899e-67
7 INTRACELLULAR SIGNAL TRANSDUCTION 425 1572 1.596e-69 1.061e-66
8 POSITIVE REGULATION OF CELL COMMUNICATION 413 1532 5.208e-67 3.029e-64
9 RESPONSE TO ENDOGENOUS STIMULUS 398 1450 8.96e-67 4.632e-64
10 REGULATION OF CELL DIFFERENTIATION 403 1492 1.604e-65 7.464e-63
11 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 456 1805 4.896e-65 2.071e-62
12 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 361 1275 6.018e-64 2.333e-61
13 RESPONSE TO OXYGEN CONTAINING COMPOUND 374 1381 8.248e-61 2.952e-58
14 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 374 1395 1.427e-59 4.743e-57
15 TISSUE DEVELOPMENT 395 1518 2.467e-59 7.652e-57
16 LOCOMOTION 322 1114 5.716e-59 1.662e-56
17 IMMUNE SYSTEM PROCESS 472 1984 7.677e-59 2.101e-56
18 REGULATION OF PHOSPHORUS METABOLIC PROCESS 411 1618 8.736e-59 2.258e-56
19 REGULATION OF PROTEIN MODIFICATION PROCESS 426 1710 1.585e-58 3.881e-56
20 RESPONSE TO LIPID 278 888 1.797e-58 4.18e-56
21 POSITIVE REGULATION OF MOLECULAR FUNCTION 439 1791 2.776e-58 6.15e-56
22 PROTEIN PHOSPHORYLATION 284 944 1.027e-55 2.173e-53
23 PHOSPHORYLATION 335 1228 6.296e-55 1.274e-52
24 POSITIVE REGULATION OF GENE EXPRESSION 421 1733 1.507e-54 2.922e-52
25 CARDIOVASCULAR SYSTEM DEVELOPMENT 251 788 3.059e-54 5.475e-52
26 CIRCULATORY SYSTEM DEVELOPMENT 251 788 3.059e-54 5.475e-52
27 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 317 1142 1.153e-53 1.987e-51
28 RESPONSE TO ORGANIC CYCLIC COMPOUND 275 917 1.38e-53 2.292e-51
29 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 426 1784 4.654e-53 7.467e-51
30 POSITIVE REGULATION OF CELL PROLIFERATION 254 814 5.387e-53 8.355e-51
31 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 457 1977 6.294e-53 9.447e-51
32 CELL DEVELOPMENT 364 1426 3.561e-52 5.179e-50
33 REGULATION OF CELL ADHESION 215 629 4.669e-52 6.583e-50
34 CELL MOTILITY 256 835 8.488e-52 1.128e-49
35 LOCALIZATION OF CELL 256 835 8.488e-52 1.128e-49
36 NEUROGENESIS 357 1402 7.691e-51 9.941e-49
37 REGULATION OF CELLULAR COMPONENT MOVEMENT 241 771 2.207e-50 2.775e-48
38 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 284 1008 2.712e-49 3.321e-47
39 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 274 957 5.403e-49 6.446e-47
40 POSITIVE REGULATION OF CATALYTIC ACTIVITY 372 1518 9.769e-49 1.136e-46
41 NEGATIVE REGULATION OF CELL DEATH 257 872 1.961e-48 2.225e-46
42 RESPONSE TO EXTERNAL STIMULUS 420 1821 5.31e-48 5.882e-46
43 EMBRYO DEVELOPMENT 260 894 8.098e-48 8.763e-46
44 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 220 689 1.214e-47 1.284e-45
45 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 365 1492 1.419e-47 1.467e-45
46 POSITIVE REGULATION OF CELL DIFFERENTIATION 245 823 5.542e-47 5.606e-45
47 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 304 1152 2.277e-46 2.254e-44
48 POSITIVE REGULATION OF CELL DEATH 200 605 7.319e-46 7.095e-44
49 RESPONSE TO HORMONE 256 893 8.228e-46 7.813e-44
50 CELL ACTIVATION 192 568 1.209e-45 1.125e-43
51 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 272 983 1.612e-45 1.47e-43
52 EPITHELIUM DEVELOPMENT 265 945 1.713e-45 1.533e-43
53 REGULATION OF KINASE ACTIVITY 233 776 2.392e-45 2.1e-43
54 REGULATION OF IMMUNE SYSTEM PROCESS 344 1403 6.395e-45 5.511e-43
55 REGULATION OF TRANSFERASE ACTIVITY 264 946 6.826e-45 5.775e-43
56 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 251 876 7.411e-45 6.158e-43
57 ORGAN MORPHOGENESIS 243 841 4.281e-44 3.434e-42
58 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 276 1021 4.219e-44 3.434e-42
59 RESPONSE TO ABIOTIC STIMULUS 276 1024 7.709e-44 6.079e-42
60 VASCULATURE DEVELOPMENT 168 469 9.52e-44 7.383e-42
61 TUBE DEVELOPMENT 185 552 2.219e-43 1.692e-41
62 IMMUNE SYSTEM DEVELOPMENT 190 582 1.115e-42 8.371e-41
63 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 232 799 1.84e-42 1.359e-40
64 REGULATION OF ORGANELLE ORGANIZATION 299 1178 6.076e-42 4.418e-40
65 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 329 1360 1.483e-41 1.062e-39
66 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 353 1517 9.269e-41 6.534e-39
67 NEGATIVE REGULATION OF GENE EXPRESSION 349 1493 9.999e-41 6.944e-39
68 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 169 498 1.872e-40 1.281e-38
69 RESPONSE TO GROWTH FACTOR 164 475 2.353e-40 1.586e-38
70 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 270 1036 5.609e-40 3.676e-38
71 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 270 1036 5.609e-40 3.676e-38
72 PEPTIDYL AMINO ACID MODIFICATION 234 841 1.747e-39 1.129e-37
73 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 238 867 4.106e-39 2.617e-37
74 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 285 1135 5.51e-39 3.464e-37
75 NEGATIVE REGULATION OF CELL PROLIFERATION 195 643 1.324e-38 8.214e-37
76 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 259 1004 1.705e-37 1.044e-35
77 NEGATIVE REGULATION OF CELL COMMUNICATION 291 1192 2.247e-37 1.358e-35
78 TISSUE MORPHOGENESIS 171 533 2.428e-37 1.449e-35
79 RESPONSE TO NITROGEN COMPOUND 232 859 6.736e-37 3.968e-35
80 MORPHOGENESIS OF AN EPITHELIUM 142 400 1.466e-36 8.53e-35
81 REGULATION OF RESPONSE TO STRESS 334 1468 2.353e-36 1.352e-34
82 RESPONSE TO STEROID HORMONE 162 497 2.395e-36 1.359e-34
83 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 220 801 3.559e-36 1.995e-34
84 CELL DEATH 255 1001 6.393e-36 3.542e-34
85 RESPONSE TO WOUNDING 174 563 1.211e-35 6.63e-34
86 NEURON DIFFERENTIATION 232 874 1.283e-35 6.941e-34
87 SKELETAL SYSTEM DEVELOPMENT 152 455 1.556e-35 8.324e-34
88 REGULATION OF CELLULAR LOCALIZATION 300 1277 3.21e-35 1.697e-33
89 REGULATION OF CELL DEVELOPMENT 224 836 4.744e-35 2.48e-33
90 POSITIVE REGULATION OF CELL ADHESION 134 376 9.47e-35 4.896e-33
91 REGULATION OF HYDROLASE ACTIVITY 307 1327 9.781e-35 5.001e-33
92 LEUKOCYTE ACTIVATION 142 414 1.15e-34 5.816e-33
93 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 162 513 1.799e-34 8.999e-33
94 RESPONSE TO OXYGEN LEVELS 119 311 2.26e-34 1.119e-32
95 CELL PROJECTION ORGANIZATION 234 902 3.024e-34 1.481e-32
96 BIOLOGICAL ADHESION 256 1032 5.224e-34 2.532e-32
97 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 152 470 1.058e-33 5.073e-32
98 CELLULAR COMPONENT MORPHOGENESIS 232 900 1.7e-33 8.072e-32
99 BLOOD VESSEL MORPHOGENESIS 129 364 3.337e-33 1.568e-31
100 GLAND DEVELOPMENT 135 395 8.193e-33 3.812e-31
101 TAXIS 149 464 1.153e-32 5.31e-31
102 LYMPHOCYTE ACTIVATION 123 342 2.05e-32 9.35e-31
103 REGULATION OF CELL CELL ADHESION 131 380 2.668e-32 1.205e-30
104 REGULATION OF MAPK CASCADE 186 660 3.498e-32 1.565e-30
105 POSITIVE REGULATION OF LOCOMOTION 139 420 4.505e-32 1.996e-30
106 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 148 465 5.68e-32 2.493e-30
107 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 202 750 5.975e-32 2.598e-30
108 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 260 1087 9.001e-32 3.878e-30
109 CELLULAR RESPONSE TO LIPID 146 457 9.488e-32 4.05e-30
110 EMBRYONIC MORPHOGENESIS 162 539 1.235e-31 5.225e-30
111 LEUKOCYTE MIGRATION 103 259 1.486e-31 6.23e-30
112 SINGLE ORGANISM CELL ADHESION 146 459 1.616e-31 6.715e-30
113 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 189 684 1.793e-31 7.382e-30
114 REGULATION OF TRANSPORT 373 1804 2.141e-31 8.738e-30
115 REGULATION OF CYTOKINE PRODUCTION 166 563 2.653e-31 1.074e-29
116 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 164 554 3.705e-31 1.486e-29
117 CELL PROLIFERATION 186 672 4.401e-31 1.75e-29
118 HEART DEVELOPMENT 146 466 1.01e-30 3.984e-29
119 EXTRACELLULAR STRUCTURE ORGANIZATION 112 304 1.104e-30 4.318e-29
120 REGULATION OF CYTOSKELETON ORGANIZATION 153 502 1.161e-30 4.502e-29
121 NEURON PROJECTION DEVELOPMENT 161 545 1.744e-30 6.708e-29
122 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 174 616 2.856e-30 1.089e-28
123 CELLULAR RESPONSE TO STRESS 332 1565 6.069e-30 2.296e-28
124 LEUKOCYTE DIFFERENTIATION 108 292 8.516e-30 3.195e-28
125 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 195 740 1.645e-29 6.124e-28
126 REGULATION OF CELL ACTIVATION 147 484 2.606e-29 9.624e-28
127 POSITIVE REGULATION OF KINASE ACTIVITY 146 482 5.58e-29 2.044e-27
128 REGULATION OF CELLULAR RESPONSE TO STRESS 185 691 6.079e-29 2.21e-27
129 NEGATIVE REGULATION OF CELL DIFFERENTIATION 170 609 6.299e-29 2.272e-27
130 NEURON DEVELOPMENT 184 687 8.223e-29 2.943e-27
131 UROGENITAL SYSTEM DEVELOPMENT 108 299 8.956e-29 3.181e-27
132 POSITIVE REGULATION OF HYDROLASE ACTIVITY 222 905 9.599e-29 3.384e-27
133 CELL CYCLE 288 1316 3.412e-28 1.194e-26
134 TUBE MORPHOGENESIS 112 323 5.168e-28 1.795e-26
135 RESPONSE TO CYTOKINE 187 714 5.813e-28 2.004e-26
136 REGULATION OF IMMUNE RESPONSE 212 858 6.538e-28 2.237e-26
137 NEGATIVE REGULATION OF MOLECULAR FUNCTION 249 1079 6.687e-28 2.271e-26
138 REGULATION OF CELL PROJECTION ORGANIZATION 158 558 1.123e-27 3.786e-26
139 RESPONSE TO ALCOHOL 119 362 2.677e-27 8.961e-26
140 REGULATION OF PROTEIN LOCALIZATION 226 950 2.943e-27 9.782e-26
141 ANGIOGENESIS 104 293 4.902e-27 1.618e-25
142 WOUND HEALING 140 470 5.172e-27 1.695e-25
143 ACTIN FILAMENT BASED PROCESS 136 450 5.981e-27 1.946e-25
144 CYTOSKELETON ORGANIZATION 206 838 8.051e-27 2.602e-25
145 NEURON PROJECTION MORPHOGENESIS 126 402 1.168e-26 3.749e-25
146 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 220 926 1.857e-26 5.917e-25
147 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 166 616 2.232e-26 7.065e-25
148 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 132 437 3.677e-26 1.156e-24
149 REGULATION OF CELL CYCLE 223 949 4.009e-26 1.252e-24
150 REGULATION OF MAP KINASE ACTIVITY 108 319 4.551e-26 1.412e-24
151 REGULATION OF NEURON DIFFERENTIATION 154 554 4.597e-26 1.417e-24
152 POSITIVE REGULATION OF TRANSPORT 220 936 8.616e-26 2.637e-24
153 CELLULAR RESPONSE TO NITROGEN COMPOUND 144 505 1.238e-25 3.764e-24
154 CELL CYCLE PROCESS 243 1081 1.715e-25 5.181e-24
155 REGULATION OF BINDING 99 283 3.111e-25 9.34e-24
156 REPRODUCTIVE SYSTEM DEVELOPMENT 124 408 6.656e-25 1.973e-23
157 PROTEIN AUTOPHOSPHORYLATION 78 192 6.647e-25 1.973e-23
158 REGULATION OF APOPTOTIC SIGNALING PATHWAY 115 363 7.236e-25 2.131e-23
159 SENSORY ORGAN DEVELOPMENT 140 493 9.326e-25 2.729e-23
160 RESPONSE TO DRUG 128 431 1.19e-24 3.462e-23
161 LEUKOCYTE CELL CELL ADHESION 92 255 1.203e-24 3.478e-23
162 CELL PART MORPHOGENESIS 165 633 1.653e-24 4.747e-23
163 POSITIVE REGULATION OF CELL CELL ADHESION 89 243 2.046e-24 5.84e-23
164 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 154 573 2.126e-24 6.032e-23
165 REGULATION OF CELLULAR COMPONENT BIOGENESIS 188 767 2.314e-24 6.526e-23
166 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 115 368 2.647e-24 7.418e-23
167 LYMPHOCYTE DIFFERENTIATION 81 209 3.349e-24 9.332e-23
168 EMBRYONIC ORGAN DEVELOPMENT 122 406 4.875e-24 1.35e-22
169 MITOTIC CELL CYCLE 187 766 5.123e-24 1.411e-22
170 REGULATION OF HOMOTYPIC CELL CELL ADHESION 102 307 5.765e-24 1.578e-22
171 HEAD DEVELOPMENT 177 709 6.277e-24 1.708e-22
172 PEPTIDYL TYROSINE MODIFICATION 75 186 9.316e-24 2.52e-22
173 CENTRAL NERVOUS SYSTEM DEVELOPMENT 204 872 1.116e-23 3.002e-22
174 POSITIVE REGULATION OF CELL ACTIVATION 102 311 1.779e-23 4.758e-22
175 NEGATIVE REGULATION OF PHOSPHORYLATION 124 422 1.832e-23 4.87e-22
176 POSITIVE REGULATION OF MAPK CASCADE 133 470 2.051e-23 5.422e-22
177 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 146 541 2.277e-23 5.953e-22
178 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 146 541 2.277e-23 5.953e-22
179 REGULATION OF BODY FLUID LEVELS 139 506 4.405e-23 1.145e-21
180 REGULATION OF CELL MORPHOGENESIS 147 552 6.6e-23 1.706e-21
181 REGULATION OF NEURON PROJECTION DEVELOPMENT 120 408 8.819e-23 2.267e-21
182 BONE DEVELOPMENT 66 156 1.918e-22 4.902e-21
183 REGULATION OF GTPASE ACTIVITY 167 673 2.533e-22 6.44e-21
184 INTERSPECIES INTERACTION BETWEEN ORGANISMS 165 662 2.791e-22 7.018e-21
185 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 165 662 2.791e-22 7.018e-21
186 REGULATION OF ACTIN FILAMENT BASED PROCESS 100 312 3.374e-22 8.439e-21
187 CELL CHEMOTAXIS 67 162 4.25e-22 1.057e-20
188 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 117 404 1.25e-21 3.094e-20
189 REGULATION OF HOMEOSTATIC PROCESS 125 447 1.385e-21 3.41e-20
190 RESPONSE TO KETONE 71 182 1.426e-21 3.492e-20
191 POSITIVE REGULATION OF IMMUNE RESPONSE 146 563 1.472e-21 3.585e-20
192 REGULATION OF INTRACELLULAR TRANSPORT 156 621 1.781e-21 4.315e-20
193 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 100 321 3.53e-21 8.511e-20
194 DEVELOPMENTAL GROWTH 102 333 5.708e-21 1.369e-19
195 RESPONSE TO ACID CHEMICAL 99 319 7.591e-21 1.811e-19
196 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 42 74 7.981e-21 1.895e-19
197 OSSIFICATION 85 251 8.627e-21 2.038e-19
198 EPITHELIAL CELL DIFFERENTIATION 132 495 9.92e-21 2.331e-19
199 CELLULAR RESPONSE TO HORMONE STIMULUS 142 552 1.198e-20 2.802e-19
200 MORPHOGENESIS OF A BRANCHING STRUCTURE 66 167 1.652e-20 3.843e-19
201 RESPONSE TO CORTICOSTEROID 68 176 1.906e-20 4.413e-19
202 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 171 724 2.04e-20 4.699e-19
203 HOMEOSTATIC PROCESS 268 1337 2.192e-20 5.024e-19
204 AGING 87 264 2.304e-20 5.256e-19
205 CELL CYCLE PHASE TRANSITION 85 255 2.753e-20 6.248e-19
206 REGULATION OF DNA METABOLIC PROCESS 102 340 3.113e-20 7.032e-19
207 REGULATION OF EPITHELIAL CELL PROLIFERATION 91 285 3.441e-20 7.734e-19
208 IN UTERO EMBRYONIC DEVELOPMENT 96 311 4.524e-20 1.012e-18
209 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 101 337 5.173e-20 1.152e-18
210 REGULATION OF LEUKOCYTE PROLIFERATION 74 206 5.907e-20 1.309e-18
211 NEGATIVE REGULATION OF CELL CYCLE 119 433 6.179e-20 1.363e-18
212 POSITIVE REGULATION OF CELL DEVELOPMENT 126 472 7.025e-20 1.542e-18
213 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 98 323 7.157e-20 1.563e-18
214 REPRODUCTION 260 1297 8.682e-20 1.888e-18
215 REGULATION OF GROWTH 154 633 9.023e-20 1.953e-18
216 RESPONSE TO INORGANIC SUBSTANCE 127 479 9.286e-20 2e-18
217 REGULATION OF HEMOPOIESIS 96 314 9.522e-20 2.042e-18
218 PLATELET ACTIVATION 59 142 9.624e-20 2.054e-18
219 CONNECTIVE TISSUE DEVELOPMENT 71 194 1.003e-19 2.131e-18
220 CELLULAR RESPONSE TO CYTOKINE STIMULUS 149 606 1.287e-19 2.721e-18
221 GROWTH 114 410 1.415e-19 2.979e-18
222 POSITIVE REGULATION OF CYTOKINE PRODUCTION 106 370 2.513e-19 5.267e-18
223 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 88 278 2.712e-19 5.633e-18
224 RESPIRATORY SYSTEM DEVELOPMENT 71 197 2.71e-19 5.633e-18
225 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 132 514 3.35e-19 6.928e-18
226 RESPONSE TO PEPTIDE 112 404 3.802e-19 7.807e-18
227 REGULATION OF CHEMOTAXIS 67 180 3.809e-19 7.807e-18
228 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 147 602 4.489e-19 9.16e-18
229 RESPONSE TO ESTROGEN 75 218 5.95e-19 1.209e-17
230 REGULATION OF OSSIFICATION 66 178 8.881e-19 1.797e-17
231 RESPONSE TO BIOTIC STIMULUS 193 886 9.358e-19 1.885e-17
232 REGULATION OF CYTOPLASMIC TRANSPORT 125 481 1.078e-18 2.163e-17
233 CELL CELL ADHESION 147 608 1.175e-18 2.337e-17
234 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 58 144 1.174e-18 2.337e-17
235 REGULATION OF SECRETION 162 699 1.529e-18 3.027e-17
236 MYELOID CELL DIFFERENTIATION 68 189 1.721e-18 3.393e-17
237 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 73 213 2.237e-18 4.392e-17
238 CARTILAGE DEVELOPMENT 58 147 3.757e-18 7.345e-17
239 APPENDAGE DEVELOPMENT 63 169 4.004e-18 7.762e-17
240 LIMB DEVELOPMENT 63 169 4.004e-18 7.762e-17
241 REGULATION OF NEURON APOPTOTIC PROCESS 68 192 4.516e-18 8.719e-17
242 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 100 352 5.015e-18 9.643e-17
243 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 54 131 5.282e-18 1.011e-16
244 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 102 365 8.211e-18 1.566e-16
245 REGULATION OF NEURON DEATH 80 252 9.609e-18 1.825e-16
246 MESENCHYME DEVELOPMENT 67 190 1.031e-17 1.949e-16
247 IMMUNE RESPONSE 223 1100 1.266e-17 2.385e-16
248 NEURON PROJECTION GUIDANCE 70 205 1.399e-17 2.626e-16
249 SKELETAL SYSTEM MORPHOGENESIS 69 201 1.73e-17 3.232e-16
250 PATTERN SPECIFICATION PROCESS 111 418 1.793e-17 3.336e-16
251 PEPTIDYL SERINE MODIFICATION 57 148 2.732e-17 5.045e-16
252 DIGESTIVE SYSTEM DEVELOPMENT 57 148 2.732e-17 5.045e-16
253 ACTIVATION OF IMMUNE RESPONSE 112 427 3.421e-17 6.292e-16
254 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 62 171 3.592e-17 6.581e-16
255 POSITIVE REGULATION OF HEMOPOIESIS 60 163 5.048e-17 9.175e-16
256 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 86 289 5.036e-17 9.175e-16
257 CELLULAR RESPONSE TO EXTERNAL STIMULUS 81 264 5.715e-17 1.035e-15
258 HEMOSTASIS 90 311 6.619e-17 1.194e-15
259 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 101 370 6.888e-17 1.237e-15
260 REGULATION OF CELLULAR PROTEIN LOCALIZATION 133 552 7.47e-17 1.337e-15
261 MAMMARY GLAND DEVELOPMENT 49 117 8.336e-17 1.486e-15
262 MUSCLE STRUCTURE DEVELOPMENT 112 432 8.566e-17 1.521e-15
263 REGULATION OF LEUKOCYTE DIFFERENTIATION 74 232 1.216e-16 2.142e-15
264 RHYTHMIC PROCESS 87 298 1.211e-16 2.142e-15
265 T CELL DIFFERENTIATION 50 123 1.784e-16 3.132e-15
266 STEM CELL DIFFERENTIATION 65 190 1.802e-16 3.152e-15
267 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 53 136 1.956e-16 3.41e-15
268 INFLAMMATORY RESPONSE 115 454 2.089e-16 3.627e-15
269 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 112 437 2.102e-16 3.635e-15
270 CELL DIVISION 116 460 2.198e-16 3.788e-15
271 RESPONSE TO NUTRIENT 65 191 2.426e-16 4.165e-15
272 NEGATIVE REGULATION OF CELL DEVELOPMENT 87 303 3.688e-16 6.286e-15
273 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 87 303 3.688e-16 6.286e-15
274 REGULATION OF ORGAN MORPHOGENESIS 75 242 4.444e-16 7.546e-15
275 CHROMOSOME ORGANIZATION 204 1009 4.696e-16 7.946e-15
276 REGULATION OF DNA BINDING 42 93 5.003e-16 8.435e-15
277 GLAND MORPHOGENESIS 43 97 5.205e-16 8.744e-15
278 APOPTOTIC SIGNALING PATHWAY 84 289 5.437e-16 9.1e-15
279 CELL CYCLE CHECKPOINT 65 194 5.828e-16 9.719e-15
280 POSITIVE REGULATION OF CELL CYCLE 92 332 6.073e-16 1.009e-14
281 INTEGRIN MEDIATED SIGNALING PATHWAY 39 82 6.28e-16 1.04e-14
282 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 102 387 6.372e-16 1.051e-14
283 DEFENSE RESPONSE 237 1231 6.499e-16 1.068e-14
284 REGULATION OF PROTEIN SECRETION 102 389 9.247e-16 1.515e-14
285 RESPONSE TO REACTIVE OXYGEN SPECIES 64 191 9.715e-16 1.586e-14
286 RESPONSE TO EXTRACELLULAR STIMULUS 111 441 1.138e-15 1.852e-14
287 RESPONSE TO RADIATION 106 413 1.225e-15 1.986e-14
288 REGULATION OF CELL SUBSTRATE ADHESION 60 173 1.262e-15 2.039e-14
289 POSITIVE REGULATION OF MAP KINASE ACTIVITY 67 207 1.485e-15 2.391e-14
290 HEART MORPHOGENESIS 68 212 1.527e-15 2.45e-14
291 REGULATION OF SYSTEM PROCESS 122 507 1.636e-15 2.616e-14
292 REGULATION OF ANATOMICAL STRUCTURE SIZE 116 472 1.645e-15 2.622e-14
293 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 52 138 1.966e-15 3.121e-14
294 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 44 104 1.972e-15 3.121e-14
295 NEGATIVE REGULATION OF CELL ADHESION 70 223 2.043e-15 3.216e-14
296 REGIONALIZATION 87 311 2.046e-15 3.216e-14
297 REGULATION OF MITOTIC CELL CYCLE 115 468 2.208e-15 3.46e-14
298 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 174 829 2.221e-15 3.467e-14
299 POSITIVE REGULATION OF DNA METABOLIC PROCESS 62 185 2.699e-15 4.201e-14
300 EPHRIN RECEPTOR SIGNALING PATHWAY 39 85 2.867e-15 4.446e-14
301 ODONTOGENESIS 44 105 3.016e-15 4.663e-14
302 CELLULAR RESPONSE TO BIOTIC STIMULUS 57 163 4.273e-15 6.583e-14
303 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 67 211 4.318e-15 6.631e-14
304 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 77 262 4.645e-15 7.109e-14
305 RESPONSE TO IONIZING RADIATION 53 145 4.701e-15 7.171e-14
306 REGULATION OF AXONOGENESIS 58 168 4.742e-15 7.211e-14
307 REGULATION OF CHROMOSOME ORGANIZATION 80 278 4.992e-15 7.567e-14
308 RESPONSE TO ESTRADIOL 53 146 6.556e-15 9.904e-14
309 REGULATION OF ERK1 AND ERK2 CASCADE 72 238 6.958e-15 1.048e-13
310 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 103 406 7.115e-15 1.068e-13
311 TISSUE REMODELING 39 87 7.508e-15 1.123e-13
312 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 93 351 8.745e-15 1.304e-13
313 SENSORY ORGAN MORPHOGENESIS 72 239 8.844e-15 1.315e-13
314 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 64 199 8.99e-15 1.332e-13
315 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 70 229 9.223e-15 1.361e-13
316 REGULATION OF INTERLEUKIN 2 PRODUCTION 28 48 9.245e-15 1.361e-13
317 HOMEOSTASIS OF NUMBER OF CELLS 59 175 9.35e-15 1.372e-13
318 REGULATION OF OSTEOBLAST DIFFERENTIATION 45 112 9.555e-15 1.398e-13
319 NEGATIVE REGULATION OF KINASE ACTIVITY 74 250 1.048e-14 1.524e-13
320 REGULATION OF MUSCLE CELL DIFFERENTIATION 54 152 1.046e-14 1.524e-13
321 MESENCHYMAL CELL DIFFERENTIATION 50 134 1.073e-14 1.556e-13
322 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 56 162 1.314e-14 1.899e-13
323 EYE DEVELOPMENT 88 326 1.421e-14 2.047e-13
324 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 52 144 1.51e-14 2.168e-13
325 IMMUNE EFFECTOR PROCESS 116 486 1.519e-14 2.174e-13
326 REGULATION OF CELL CYCLE PROCESS 128 558 1.59e-14 2.269e-13
327 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 94 360 1.659e-14 2.361e-13
328 REGULATION OF LEUKOCYTE MIGRATION 53 149 1.738e-14 2.465e-13
329 CELLULAR RESPONSE TO DNA DAMAGE STIMULUS 154 720 1.898e-14 2.684e-13
330 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 63 197 1.955e-14 2.748e-13
331 EMBRYONIC ORGAN MORPHOGENESIS 79 279 1.952e-14 2.748e-13
332 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 82 296 2.383e-14 3.339e-13
333 CELL SUBSTRATE ADHESION 56 164 2.399e-14 3.352e-13
334 REGULATION OF VASCULATURE DEVELOPMENT 70 233 2.424e-14 3.377e-13
335 B CELL ACTIVATION 49 132 2.499e-14 3.465e-13
336 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 51 141 2.502e-14 3.465e-13
337 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 66 213 2.593e-14 3.58e-13
338 REGULATION OF CELL GROWTH 99 391 2.734e-14 3.763e-13
339 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 40 94 2.928e-14 4.019e-13
340 RESPONSE TO OXIDATIVE STRESS 92 352 2.971e-14 4.065e-13
341 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 60 184 3.064e-14 4.18e-13
342 CELLULAR RESPONSE TO ACID CHEMICAL 58 175 3.685e-14 5.014e-13
343 REGENERATION 55 161 3.994e-14 5.418e-13
344 CELL CYCLE G2 M PHASE TRANSITION 50 138 4.145e-14 5.607e-13
345 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 40 95 4.494e-14 6.061e-13
346 NEGATIVE REGULATION OF NEURON DEATH 57 171 4.621e-14 6.215e-13
347 KIDNEY EPITHELIUM DEVELOPMENT 47 125 4.801e-14 6.419e-13
348 CELLULAR RESPONSE TO OXYGEN LEVELS 51 143 4.789e-14 6.419e-13
349 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 55 162 5.372e-14 7.162e-13
350 CELLULAR RESPONSE TO ABIOTIC STIMULUS 75 263 5.973e-14 7.941e-13
351 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 53 153 6.056e-14 8.028e-13
352 COLLAGEN FIBRIL ORGANIZATION 24 38 6.212e-14 8.211e-13
353 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 48 131 8.145e-14 1.074e-12
354 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 53 154 8.203e-14 1.078e-12
355 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 66 218 8.877e-14 1.164e-12
356 RESPONSE TO BACTERIUM 121 528 9.126e-14 1.193e-12
357 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 78 282 1.119e-13 1.458e-12
358 CELLULAR RESPONSE TO ALCOHOL 44 115 1.493e-13 1.94e-12
359 RESPONSE TO MECHANICAL STIMULUS 64 210 1.5e-13 1.944e-12
360 EAR DEVELOPMENT 61 195 1.533e-13 1.982e-12
361 REGULATION OF DEVELOPMENTAL GROWTH 79 289 1.544e-13 1.99e-12
362 REGULATION OF RESPONSE TO WOUNDING 101 413 1.582e-13 2.034e-12
363 POSITIVE REGULATION OF CHEMOTAXIS 45 120 1.848e-13 2.368e-12
364 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 60 191 1.972e-13 2.521e-12
365 RAS PROTEIN SIGNAL TRANSDUCTION 50 143 2.049e-13 2.612e-12
366 POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 21 31 2.99e-13 3.802e-12
367 MULTI MULTICELLULAR ORGANISM PROCESS 64 213 3.09e-13 3.918e-12
368 REGULATION OF CELLULAR COMPONENT SIZE 87 337 3.162e-13 3.998e-12
369 NEGATIVE REGULATION OF BINDING 47 131 3.63e-13 4.577e-12
370 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 93 372 3.72e-13 4.678e-12
371 NEGATIVE REGULATION OF MAPK CASCADE 50 145 3.782e-13 4.743e-12
372 NEGATIVE REGULATION OF CELL CYCLE PROCESS 64 214 3.916e-13 4.898e-12
373 SECRETION 129 588 4.048e-13 5.05e-12
374 REGULATION OF DEFENSE RESPONSE 156 759 4.113e-13 5.117e-12
375 CHROMATIN MODIFICATION 121 539 4.196e-13 5.207e-12
376 CELLULAR RESPONSE TO MECHANICAL STIMULUS 35 80 4.361e-13 5.397e-12
377 COVALENT CHROMATIN MODIFICATION 88 345 4.806e-13 5.932e-12
378 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 40 101 5.051e-13 6.217e-12
379 FOREBRAIN DEVELOPMENT 90 357 5.365e-13 6.587e-12
380 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 59 190 5.452e-13 6.676e-12
381 POSITIVE REGULATION OF CELL CYCLE PROCESS 70 247 5.704e-13 6.966e-12
382 MUSCLE CELL DIFFERENTIATION 68 237 6.456e-13 7.864e-12
383 REGULATION OF CATABOLIC PROCESS 151 731 6.583e-13 7.997e-12
384 CYTOKINE MEDIATED SIGNALING PATHWAY 106 452 6.973e-13 8.45e-12
385 POSITIVE REGULATION OF GROWTH 68 238 8.029e-13 9.703e-12
386 MYELOID LEUKOCYTE ACTIVATION 39 98 8.203e-13 9.888e-12
387 MITOTIC CELL CYCLE CHECKPOINT 48 139 1.047e-12 1.259e-11
388 REGULATION OF PROTEIN BINDING 54 168 1.123e-12 1.347e-11
389 REGULATION OF CELL DIVISION 74 272 1.172e-12 1.402e-11
390 MYELOID LEUKOCYTE MIGRATION 39 99 1.203e-12 1.435e-11
391 ORGAN REGENERATION 35 83 1.627e-12 1.936e-11
392 BONE MORPHOGENESIS 34 79 1.669e-12 1.981e-11
393 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 60 200 1.822e-12 2.158e-11
394 POSITIVE REGULATION OF BINDING 45 127 1.898e-12 2.236e-11
395 PROTEIN LOCALIZATION 305 1805 1.896e-12 2.236e-11
396 CELL JUNCTION ORGANIZATION 57 185 1.929e-12 2.266e-11
397 REGULATION OF LYMPHOCYTE DIFFERENTIATION 46 132 2.134e-12 2.501e-11
398 FC RECEPTOR SIGNALING PATHWAY 61 206 2.229e-12 2.606e-11
399 ENDOCRINE SYSTEM DEVELOPMENT 44 123 2.289e-12 2.669e-11
400 REGULATION OF DNA REPLICATION 52 161 2.377e-12 2.765e-11
401 POSITIVE REGULATION OF OSSIFICATION 35 84 2.479e-12 2.877e-11
402 REGULATION OF T CELL PROLIFERATION 49 147 2.739e-12 3.17e-11
403 MITOTIC NUCLEAR DIVISION 89 361 2.75e-12 3.176e-11
404 REGULATION OF WNT SIGNALING PATHWAY 80 310 2.9e-12 3.34e-11
405 DNA METABOLIC PROCESS 153 758 3.101e-12 3.562e-11
406 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 63 218 3.2e-12 3.667e-11
407 ESTABLISHMENT OF LOCALIZATION IN CELL 286 1676 3.315e-12 3.79e-11
408 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 45 129 3.549e-12 4.048e-11
409 POSITIVE REGULATION OF NEURON DIFFERENTIATION 79 306 3.878e-12 4.411e-11
410 NEGATIVE REGULATION OF CELL ACTIVATION 51 158 3.956e-12 4.479e-11
411 RESPONSE TO PURINE CONTAINING COMPOUND 51 158 3.956e-12 4.479e-11
412 RESPONSE TO VITAMIN 38 98 4.151e-12 4.688e-11
413 ACTIVATION OF PROTEIN KINASE ACTIVITY 74 279 4.547e-12 5.123e-11
414 POSITIVE REGULATION OF SECRETION 90 370 4.617e-12 5.189e-11
415 ORGANELLE FISSION 111 496 4.904e-12 5.499e-11
416 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 63 220 4.966e-12 5.555e-11
417 ANTERIOR POSTERIOR PATTERN SPECIFICATION 58 194 4.978e-12 5.555e-11
418 CELLULAR RESPONSE TO PEPTIDE 73 274 5.017e-12 5.585e-11
419 REGULATION OF CELL MATRIX ADHESION 36 90 5.157e-12 5.727e-11
420 CELLULAR RESPONSE TO OXIDATIVE STRESS 56 184 5.228e-12 5.792e-11
421 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 46 135 5.286e-12 5.842e-11
422 PROTEIN COMPLEX SUBUNIT ORGANIZATION 264 1527 6.102e-12 6.728e-11
423 LEUKOCYTE CHEMOTAXIS 42 117 6.299e-12 6.928e-11
424 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 62 216 6.55e-12 7.188e-11
425 POSITIVE REGULATION OF T CELL PROLIFERATION 37 95 6.784e-12 7.427e-11
426 POSITIVE REGULATION OF PROTEIN SECRETION 61 211 6.923e-12 7.561e-11
427 RESPONSE TO METAL ION 83 333 8.152e-12 8.883e-11
428 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 13 14 8.542e-12 9.287e-11
429 MYELOID LEUKOCYTE DIFFERENTIATION 37 96 9.811e-12 1.064e-10
430 REGULATION OF PROTEOLYSIS 144 711 1.069e-11 1.157e-10
431 REGULATION OF CHROMATIN ORGANIZATION 49 152 1.096e-11 1.183e-10
432 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 53 172 1.138e-11 1.225e-10
433 PLACENTA DEVELOPMENT 46 138 1.265e-11 1.36e-10
434 CHONDROCYTE DIFFERENTIATION 28 60 1.402e-11 1.5e-10
435 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 28 60 1.402e-11 1.5e-10
436 NEPHRON DEVELOPMENT 41 115 1.443e-11 1.54e-10
437 REGULATION OF CELL JUNCTION ASSEMBLY 30 68 1.567e-11 1.668e-10
438 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 22 39 1.751e-11 1.86e-10
439 REGULATION OF MICROTUBULE BASED PROCESS 66 243 2.089e-11 2.214e-10
440 CELL FATE COMMITMENT 63 227 2.187e-11 2.313e-10
441 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 38 103 2.44e-11 2.568e-10
442 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 43 126 2.439e-11 2.568e-10
443 ENDOCYTOSIS 111 509 2.69e-11 2.825e-10
444 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 59 207 2.889e-11 3.027e-10
445 PEPTIDYL LYSINE MODIFICATION 78 312 2.956e-11 3.091e-10
446 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 42 122 3.01e-11 3.14e-10
447 DNA INTEGRITY CHECKPOINT 47 146 3.034e-11 3.158e-10
448 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 38 104 3.417e-11 3.549e-10
449 LYMPHOCYTE COSTIMULATION 32 78 3.505e-11 3.632e-10
450 REGULATION OF METAL ION TRANSPORT 80 325 3.788e-11 3.917e-10
451 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 48 152 4.03e-11 4.157e-10
452 REGULATION OF EMBRYONIC DEVELOPMENT 40 114 4.51e-11 4.643e-10
453 SINGLE ORGANISM CELLULAR LOCALIZATION 170 898 4.615e-11 4.741e-10
454 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 36 96 4.71e-11 4.817e-10
455 CARDIOCYTE DIFFERENTIATION 36 96 4.71e-11 4.817e-10
456 NEGATIVE REGULATION OF CELL CELL ADHESION 45 138 4.882e-11 4.982e-10
457 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 26 55 5.214e-11 5.308e-10
458 REGULATION OF CARTILAGE DEVELOPMENT 28 63 5.988e-11 6.077e-10
459 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 63 232 5.995e-11 6.077e-10
460 CHEMICAL HOMEOSTASIS 166 874 6.067e-11 6.137e-10
461 REGULATION OF PROTEIN COMPLEX ASSEMBLY 88 375 6.118e-11 6.175e-10
462 RESPONSE TO ORGANOPHOSPHORUS 45 139 6.415e-11 6.461e-10
463 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 56 195 6.631e-11 6.65e-10
464 REGULATION OF MUSCLE SYSTEM PROCESS 56 195 6.631e-11 6.65e-10
465 REGULATION OF JNK CASCADE 49 159 6.709e-11 6.713e-10
466 AMEBOIDAL TYPE CELL MIGRATION 48 154 6.734e-11 6.724e-10
467 SEX DIFFERENTIATION 69 266 7.052e-11 7.026e-10
468 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 32 80 7.762e-11 7.718e-10
469 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 46 145 8.579e-11 8.511e-10
470 LEUKOCYTE HOMEOSTASIS 27 60 9.244e-11 9.152e-10
471 REGULATION OF PHOSPHOLIPASE ACTIVITY 28 64 9.468e-11 9.354e-10
472 POSITIVE REGULATION OF CELL CYCLE ARREST 33 85 1.018e-10 1.003e-09
473 NEGATIVE REGULATION OF TRANSPORT 101 458 1.097e-10 1.079e-09
474 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 32 81 1.141e-10 1.12e-09
475 POSITIVE REGULATION OF DNA BINDING 22 42 1.244e-10 1.218e-09
476 REGULATION OF CELL CYCLE ARREST 38 108 1.247e-10 1.218e-09
477 MESONEPHROS DEVELOPMENT 34 90 1.278e-10 1.247e-09
478 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 63 236 1.305e-10 1.27e-09
479 CELLULAR RESPONSE TO KETONE 30 73 1.36e-10 1.321e-09
480 OVULATION CYCLE 39 113 1.388e-10 1.345e-09
481 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 26 57 1.416e-10 1.37e-09
482 CARDIAC CHAMBER MORPHOGENESIS 37 104 1.51e-10 1.454e-09
483 POSITIVE REGULATION OF PROTEIN IMPORT 37 104 1.51e-10 1.454e-09
484 SECRETION BY CELL 105 486 1.643e-10 1.58e-09
485 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 38 109 1.701e-10 1.629e-09
486 RESPONSE TO HYDROGEN PEROXIDE 38 109 1.701e-10 1.629e-09
487 VESICLE MEDIATED TRANSPORT 217 1239 1.742e-10 1.665e-09
488 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 43 133 1.777e-10 1.695e-09
489 SOMITE DEVELOPMENT 31 78 1.856e-10 1.766e-09
490 RESPONSE TO GAMMA RADIATION 24 50 1.924e-10 1.827e-09
491 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 26 58 2.284e-10 2.165e-09
492 SOMITOGENESIS 27 62 2.325e-10 2.199e-09
493 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 44 139 2.371e-10 2.233e-09
494 REGULATION OF CELL SHAPE 44 139 2.371e-10 2.233e-09
495 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 51 175 2.617e-10 2.455e-09
496 CHROMATIN ORGANIZATION 132 663 2.614e-10 2.455e-09
497 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 31 79 2.717e-10 2.544e-09
498 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 69 274 2.883e-10 2.694e-09
499 EPITHELIAL CELL DEVELOPMENT 53 186 2.923e-10 2.726e-09
500 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 33 88 2.992e-10 2.784e-09
501 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 18 30 3.041e-10 2.824e-09
502 POSITIVE REGULATION OF CHROMOSOME ORGANIZATION 46 150 3.057e-10 2.834e-09
503 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 21 40 3.111e-10 2.878e-09
504 CELL AGING 28 67 3.493e-10 3.225e-09
505 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 40 121 3.587e-10 3.305e-09
506 REGULATION OF IMMUNE EFFECTOR PROCESS 94 424 3.617e-10 3.326e-09
507 RESPONSE TO RETINOIC ACID 37 107 3.845e-10 3.529e-09
508 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 43 136 3.942e-10 3.61e-09
509 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 45 146 3.956e-10 3.617e-09
510 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 35 98 4.164e-10 3.792e-09
511 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 35 98 4.164e-10 3.792e-09
512 B CELL DIFFERENTIATION 33 89 4.228e-10 3.835e-09
513 SEGMENTATION 33 89 4.228e-10 3.835e-09
514 ADAPTIVE IMMUNE RESPONSE 71 288 4.403e-10 3.986e-09
515 REGULATION OF PROTEIN IMPORT 52 183 4.787e-10 4.325e-09
516 DIGESTIVE TRACT MORPHOGENESIS 23 48 4.804e-10 4.332e-09
517 REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 51 178 5.088e-10 4.579e-09
518 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 28 68 5.282e-10 4.745e-09
519 REGULATION OF PROTEIN TARGETING 74 307 5.662e-10 5.076e-09
520 ACTIN FILAMENT ORGANIZATION 50 174 6.706e-10 6.001e-09
521 PHAGOCYTOSIS 53 190 6.821e-10 6.092e-09
522 FC GAMMA RECEPTOR SIGNALING PATHWAY 34 95 6.915e-10 6.164e-09
523 POSITIVE REGULATION OF DNA REPLICATION 32 86 6.985e-10 6.215e-09
524 HISTONE PHOSPHORYLATION 16 25 7.668e-10 6.809e-09
525 MESENCHYME MORPHOGENESIS 20 38 7.786e-10 6.901e-09
526 MITOTIC DNA INTEGRITY CHECKPOINT 35 100 7.833e-10 6.929e-09
527 POSITIVE REGULATION OF AXONOGENESIS 28 69 7.908e-10 6.982e-09
528 REGULATION OF CYTOKINE SECRETION 45 149 8.237e-10 7.259e-09
529 CARDIAC CHAMBER DEVELOPMENT 44 144 8.396e-10 7.385e-09
530 MULTICELLULAR ORGANISM REPRODUCTION 146 768 8.51e-10 7.471e-09
531 MUSCLE TISSUE DEVELOPMENT 68 275 8.929e-10 7.824e-09
532 POSITIVE REGULATION OF DEFENSE RESPONSE 83 364 9.437e-10 8.254e-09
533 CELL PROJECTION ASSEMBLY 66 264 9.678e-10 8.448e-09
534 CYTOKINE PRODUCTION 39 120 1.041e-09 9.067e-09
535 CARDIAC MUSCLE TISSUE DEVELOPMENT 43 140 1.088e-09 9.461e-09
536 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 42 135 1.094e-09 9.5e-09
537 REGULATION OF CHONDROCYTE DIFFERENTIATION 22 46 1.2e-09 1.04e-08
538 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 46 156 1.276e-09 1.1e-08
539 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 46 156 1.276e-09 1.1e-08
540 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 46 156 1.276e-09 1.1e-08
541 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 18 32 1.316e-09 1.13e-08
542 BLOOD VESSEL REMODELING 18 32 1.316e-09 1.13e-08
543 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 30 79 1.338e-09 1.142e-08
544 NEGATIVE REGULATION OF PROTEIN BINDING 30 79 1.338e-09 1.142e-08
545 ERBB SIGNALING PATHWAY 30 79 1.338e-09 1.142e-08
546 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 26 62 1.356e-09 1.155e-08
547 REGULATION OF PROTEIN KINASE B SIGNALING 39 121 1.365e-09 1.161e-08
548 ESTABLISHMENT OF CELL POLARITY 32 88 1.373e-09 1.164e-08
549 LEUKOCYTE PROLIFERATION 32 88 1.373e-09 1.164e-08
550 POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 25 58 1.399e-09 1.183e-08
551 REGULATION OF ENDOCYTOSIS 54 199 1.414e-09 1.194e-08
552 REGULATION OF MYELOID CELL DIFFERENTIATION 51 183 1.474e-09 1.243e-08
553 ARTERY DEVELOPMENT 29 75 1.53e-09 1.285e-08
554 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 29 75 1.53e-09 1.285e-08
555 REGULATION OF PEPTIDASE ACTIVITY 87 392 1.545e-09 1.295e-08
556 REGULATION OF T CELL DIFFERENTIATION 36 107 1.562e-09 1.306e-08
557 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 57 216 1.563e-09 1.306e-08
558 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 60 233 1.639e-09 1.367e-08
559 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 45 152 1.671e-09 1.391e-08
560 CELLULAR CHEMICAL HOMEOSTASIS 115 570 1.703e-09 1.415e-08
561 REGULATION OF MUSCLE CONTRACTION 44 147 1.728e-09 1.433e-08
562 REGULATION OF VESICLE MEDIATED TRANSPORT 98 462 1.87e-09 1.549e-08
563 POSITIVE REGULATION OF PROTEOLYSIS 82 363 1.902e-09 1.572e-08
564 REGULATION OF NUCLEAR DIVISION 47 163 1.91e-09 1.576e-08
565 REGULATION OF ION HOMEOSTASIS 54 201 2.09e-09 1.722e-08
566 ARTERY MORPHOGENESIS 23 51 2.154e-09 1.771e-08
567 POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 25 59 2.16e-09 1.773e-08
568 POSITIVE REGULATION OF CELL GROWTH 44 148 2.186e-09 1.79e-08
569 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 31 85 2.276e-09 1.861e-08
570 MAMMARY GLAND MORPHOGENESIS 20 40 2.536e-09 2.07e-08
571 REGULATION OF FIBROBLAST PROLIFERATION 30 81 2.69e-09 2.192e-08
572 CELL MATRIX ADHESION 38 119 2.968e-09 2.414e-08
573 INOSITOL LIPID MEDIATED SIGNALING 39 124 3.01e-09 2.444e-08
574 PROTEIN LOCALIZATION TO ORGANELLE 112 556 3.052e-09 2.474e-08
575 REGULATION OF PROTEIN ACETYLATION 26 64 3.079e-09 2.491e-08
576 REGULATION OF LIPID KINASE ACTIVITY 22 48 3.302e-09 2.667e-08
577 GASTRULATION 45 155 3.308e-09 2.667e-08
578 REGULATION OF CALCIUM ION TRANSPORT 55 209 3.353e-09 2.699e-08
579 POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 23 52 3.439e-09 2.764e-08
580 MULTICELLULAR ORGANISMAL HOMEOSTASIS 66 272 3.585e-09 2.876e-08
581 FORMATION OF PRIMARY GERM LAYER 36 110 3.654e-09 2.926e-08
582 REGULATION OF EPITHELIAL CELL MIGRATION 47 166 3.665e-09 2.93e-08
583 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 37 115 3.783e-09 3.02e-08
584 NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION 57 221 3.906e-09 3.112e-08
585 NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION 33 96 4.004e-09 3.179e-08
586 REGULATION OF LEUKOCYTE CHEMOTAXIS 33 96 4.004e-09 3.179e-08
587 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 84 381 4.105e-09 3.254e-08
588 WNT SIGNALING PATHWAY 79 351 4.465e-09 3.533e-08
589 RESPONSE TO FLUID SHEAR STRESS 18 34 4.887e-09 3.861e-08
590 RESPONSE TO FIBROBLAST GROWTH FACTOR 37 116 4.939e-09 3.895e-08
591 OSTEOBLAST DIFFERENTIATION 39 126 5.007e-09 3.923e-08
592 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 38 121 5.003e-09 3.923e-08
593 SPROUTING ANGIOGENESIS 21 45 5.008e-09 3.923e-08
594 ENDOCHONDRAL BONE MORPHOGENESIS 21 45 5.008e-09 3.923e-08
595 MULTI ORGANISM REPRODUCTIVE PROCESS 161 891 5.082e-09 3.974e-08
596 REGULATION OF ERBB SIGNALING PATHWAY 30 83 5.255e-09 4.089e-08
597 EMBRYONIC PLACENTA DEVELOPMENT 30 83 5.255e-09 4.089e-08
598 RESPONSE TO FATTY ACID 30 83 5.255e-09 4.089e-08
599 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 22 49 5.336e-09 4.145e-08
600 NEGATIVE REGULATION OF LOCOMOTION 64 263 5.459e-09 4.233e-08
601 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 43 147 5.71e-09 4.42e-08
602 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 49 179 5.872e-09 4.539e-08
603 MYELOID CELL HOMEOSTASIS 31 88 6.006e-09 4.634e-08
604 RESPONSE TO TOXIC SUBSTANCE 60 241 6.534e-09 5.034e-08
605 CELLULAR HOMEOSTASIS 129 676 6.603e-09 5.078e-08
606 MULTICELLULAR ORGANISM METABOLIC PROCESS 32 93 6.672e-09 5.123e-08
607 TISSUE MIGRATION 30 84 7.271e-09 5.574e-08
608 CARDIAC VENTRICLE MORPHOGENESIS 25 62 7.413e-09 5.673e-08
609 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 20 42 7.5e-09 5.73e-08
610 LYMPHOCYTE HOMEOSTASIS 22 50 8.484e-09 6.461e-08
611 REGULATION OF ADHERENS JUNCTION ORGANIZATION 22 50 8.484e-09 6.461e-08
612 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 27 71 8.532e-09 6.487e-08
613 REGULATION OF JAK STAT CASCADE 42 144 9.401e-09 7.124e-08
614 REGULATION OF STAT CASCADE 42 144 9.401e-09 7.124e-08
615 REGULATION OF B CELL DIFFERENTIATION 14 22 1.016e-08 7.685e-08
616 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 40 134 1.018e-08 7.689e-08
617 CELL JUNCTION ASSEMBLY 39 129 1.046e-08 7.89e-08
618 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 35 109 1.049e-08 7.899e-08
619 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 38 124 1.065e-08 8.007e-08
620 REGULATION OF PHOSPHOLIPASE C ACTIVITY 19 39 1.106e-08 8.298e-08
621 REGULATION OF CELL SIZE 47 172 1.267e-08 9.494e-08
622 REGULATION OF B CELL PROLIFERATION 23 55 1.284e-08 9.601e-08
623 CELL GROWTH 40 135 1.286e-08 9.604e-08
624 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 22 51 1.329e-08 9.907e-08
625 RESPONSE TO INTERLEUKIN 1 36 115 1.383e-08 1.029e-07
626 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 26 68 1.405e-08 1.044e-07
627 CIRCULATORY SYSTEM PROCESS 80 366 1.436e-08 1.065e-07
628 REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 45 162 1.488e-08 1.102e-07
629 STRIATED MUSCLE CELL DIFFERENTIATION 47 173 1.546e-08 1.144e-07
630 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 18 36 1.598e-08 1.177e-07
631 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 18 36 1.598e-08 1.177e-07
632 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 18 36 1.598e-08 1.177e-07
633 REGULATION OF LIPID METABOLIC PROCESS 66 282 1.659e-08 1.218e-07
634 MUSCLE SYSTEM PROCESS 66 282 1.659e-08 1.218e-07
635 INNATE IMMUNE RESPONSE 119 619 1.665e-08 1.22e-07
636 REGULATION OF INFLAMMATORY RESPONSE 68 294 1.674e-08 1.225e-07
637 REGULATION OF EXTENT OF CELL GROWTH 33 101 1.692e-08 1.236e-07
638 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 27 73 1.715e-08 1.249e-07
639 INTRINSIC APOPTOTIC SIGNALING PATHWAY 43 152 1.715e-08 1.249e-07
640 CARDIAC VENTRICLE DEVELOPMENT 34 106 1.747e-08 1.27e-07
641 REGULATION OF B CELL ACTIVATION 37 121 1.766e-08 1.282e-07
642 NEGATIVE REGULATION OF DNA METABOLIC PROCESS 35 111 1.777e-08 1.288e-07
643 EPIDERMIS DEVELOPMENT 61 253 1.787e-08 1.293e-07
644 CELLULAR MACROMOLECULE LOCALIZATION 207 1234 1.827e-08 1.32e-07
645 REGULATION OF BLOOD CIRCULATION 68 295 1.933e-08 1.394e-07
646 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 15 26 2.006e-08 1.445e-07
647 MICROTUBULE BASED PROCESS 104 522 2.037e-08 1.465e-07
648 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 38 127 2.197e-08 1.578e-07
649 REGULATION OF LIPASE ACTIVITY 29 83 2.275e-08 1.631e-07
650 GLIOGENESIS 47 175 2.287e-08 1.637e-07
651 EAR MORPHOGENESIS 35 112 2.298e-08 1.643e-07
652 CELLULAR RESPONSE TO RETINOIC ACID 25 65 2.311e-08 1.649e-07
653 CARDIAC MUSCLE CELL DIFFERENTIATION 27 74 2.403e-08 1.712e-07
654 ANATOMICAL STRUCTURE HOMEOSTASIS 66 285 2.572e-08 1.83e-07
655 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 24 61 2.614e-08 1.852e-07
656 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 24 61 2.614e-08 1.852e-07
657 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 43 154 2.615e-08 1.852e-07
658 NEPHRON EPITHELIUM DEVELOPMENT 31 93 2.685e-08 1.899e-07
659 NEURAL TUBE DEVELOPMENT 42 149 2.806e-08 1.981e-07
660 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 32 98 2.821e-08 1.989e-07
661 ESTABLISHMENT OF PROTEIN LOCALIZATION 232 1423 2.863e-08 2.015e-07
662 ENDOTHELIAL CELL MIGRATION 23 57 2.895e-08 2.035e-07
663 SECOND MESSENGER MEDIATED SIGNALING 44 160 2.972e-08 2.086e-07
664 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 29 84 3.091e-08 2.166e-07
665 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 22 53 3.122e-08 2.185e-07
666 THYMOCYTE AGGREGATION 20 45 3.271e-08 2.282e-07
667 T CELL DIFFERENTIATION IN THYMUS 20 45 3.271e-08 2.282e-07
668 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 49 188 3.296e-08 2.296e-07
669 NEURAL CREST CELL DIFFERENTIATION 27 75 3.342e-08 2.324e-07
670 INTERACTION WITH HOST 39 134 3.348e-08 2.325e-07
671 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 56 228 3.423e-08 2.374e-07
672 TUBE FORMATION 38 129 3.502e-08 2.424e-07
673 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 32 99 3.708e-08 2.562e-07
674 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 41 145 3.711e-08 2.562e-07
675 REGULATION OF PROTEIN COMPLEX DISASSEMBLY 54 217 3.727e-08 2.569e-07
676 POSITIVE REGULATION OF ENDOCYTOSIS 35 114 3.799e-08 2.615e-07
677 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 43 156 3.946e-08 2.712e-07
678 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 17 34 4.02e-08 2.759e-07
679 PALATE DEVELOPMENT 29 85 4.175e-08 2.857e-07
680 POSITIVE REGULATION OF CHROMATIN MODIFICATION 29 85 4.175e-08 2.857e-07
681 REGULATION OF PROTEIN POLYMERIZATION 46 173 4.474e-08 3.057e-07
682 B CELL RECEPTOR SIGNALING PATHWAY 22 54 4.692e-08 3.201e-07
683 REGULATION OF ANOIKIS 14 24 4.964e-08 3.382e-07
684 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 20 46 5.156e-08 3.503e-07
685 REGULATION OF JUN KINASE ACTIVITY 28 81 5.156e-08 3.503e-07
686 CHONDROCYTE DEVELOPMENT 13 21 5.618e-08 3.81e-07
687 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 16 31 5.674e-08 3.843e-07
688 REGULATION OF AUTOPHAGY 59 249 5.904e-08 3.993e-07
689 FEMALE SEX DIFFERENTIATION 35 116 6.185e-08 4.177e-07
690 CELL CYCLE G1 S PHASE TRANSITION 34 111 6.305e-08 4.244e-07
691 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 27 77 6.321e-08 4.244e-07
692 G1 S TRANSITION OF MITOTIC CELL CYCLE 34 111 6.305e-08 4.244e-07
693 DEVELOPMENTAL CELL GROWTH 27 77 6.321e-08 4.244e-07
694 REGULATION OF ALPHA BETA T CELL ACTIVATION 25 68 6.618e-08 4.437e-07
695 CRANIAL SKELETAL SYSTEM DEVELOPMENT 22 55 6.965e-08 4.656e-07
696 ACTIN CYTOSKELETON REORGANIZATION 22 55 6.965e-08 4.656e-07
697 G1 DNA DAMAGE CHECKPOINT 26 73 7.681e-08 5.127e-07
698 MAMMARY GLAND DUCT MORPHOGENESIS 15 28 7.739e-08 5.159e-07
699 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 18 39 7.779e-08 5.171e-07
700 PLATELET AGGREGATION 18 39 7.779e-08 5.171e-07
701 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 30 92 7.85e-08 5.211e-07
702 REGULATION OF SEQUESTERING OF CALCIUM ION 33 107 8.169e-08 5.415e-07
703 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 32 102 8.184e-08 5.417e-07
704 MITOTIC SPINDLE ORGANIZATION 25 69 9.238e-08 6.106e-07
705 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 60 258 9.31e-08 6.145e-07
706 MESODERM DEVELOPMENT 35 118 9.922e-08 6.539e-07
707 PATTERNING OF BLOOD VESSELS 16 32 1.012e-07 6.653e-07
708 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 16 32 1.012e-07 6.653e-07
709 EPITHELIAL TO MESENCHYMAL TRANSITION 22 56 1.022e-07 6.695e-07
710 OUTFLOW TRACT MORPHOGENESIS 22 56 1.022e-07 6.695e-07
711 REGULATION OF REPRODUCTIVE PROCESS 37 129 1.13e-07 7.395e-07
712 REGULATION OF ACTIN FILAMENT LENGTH 42 156 1.164e-07 7.606e-07
713 T CELL PROLIFERATION 17 36 1.178e-07 7.674e-07
714 T CELL SELECTION 17 36 1.178e-07 7.674e-07
715 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 20 48 1.221e-07 7.949e-07
716 REGULATION OF CELLULAR EXTRAVASATION 13 22 1.226e-07 7.971e-07
717 REGULATION OF CELL CYCLE PHASE TRANSITION 70 321 1.244e-07 8.071e-07
718 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 18 40 1.261e-07 8.17e-07
719 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 19 44 1.27e-07 8.219e-07
720 NOTCH SIGNALING PATHWAY 34 114 1.298e-07 8.389e-07
721 REGULATION OF DNA BIOSYNTHETIC PROCESS 30 94 1.347e-07 8.694e-07
722 REGULATION OF INTERLEUKIN 6 PRODUCTION 32 104 1.357e-07 8.745e-07
723 RESPONSE TO CARBOHYDRATE 44 168 1.397e-07 8.994e-07
724 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 26 75 1.436e-07 9.215e-07
725 GRANULOCYTE MIGRATION 26 75 1.436e-07 9.215e-07
726 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 49 197 1.591e-07 1.02e-06
727 EYE MORPHOGENESIS 38 136 1.622e-07 1.038e-06
728 PROTEIN SUMOYLATION 34 115 1.639e-07 1.048e-06
729 REGULATION OF HORMONE SECRETION 60 262 1.653e-07 1.055e-06
730 REGULATION OF PEPTIDE TRANSPORT 59 256 1.656e-07 1.055e-06
731 MAMMARY GLAND EPITHELIUM DEVELOPMENT 21 53 1.672e-07 1.064e-06
732 CYCLOOXYGENASE PATHWAY 9 11 1.682e-07 1.069e-06
733 REGULATION OF PROTEIN CATABOLIC PROCESS 81 393 1.71e-07 1.086e-06
734 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 31 100 1.756e-07 1.112e-06
735 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 31 100 1.756e-07 1.112e-06
736 DNA RECOMBINATION 52 215 1.767e-07 1.117e-06
737 REGULATION OF TISSUE REMODELING 23 62 1.821e-07 1.15e-06
738 GLOMERULUS DEVELOPMENT 20 49 1.839e-07 1.158e-06
739 CARDIAC SEPTUM MORPHOGENESIS 20 49 1.839e-07 1.158e-06
740 REGULATION OF WOUND HEALING 36 126 1.855e-07 1.167e-06
741 POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 17 37 1.943e-07 1.22e-06
742 CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 176 1047 1.966e-07 1.233e-06
743 CELL SUBSTRATE JUNCTION ASSEMBLY 18 41 2.004e-07 1.255e-06
744 NEGATIVE REGULATION OF CELL GROWTH 44 170 2.014e-07 1.258e-06
745 NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY 44 170 2.014e-07 1.258e-06
746 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 27 81 2.086e-07 1.301e-06
747 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 24 67 2.131e-07 1.327e-06
748 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 33 111 2.147e-07 1.335e-06
749 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 28 86 2.187e-07 1.358e-06
750 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 32 106 2.212e-07 1.372e-06
751 ORGANELLE LOCALIZATION 84 415 2.298e-07 1.424e-06
752 TISSUE HOMEOSTASIS 44 171 2.411e-07 1.492e-06
753 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 89 448 2.419e-07 1.495e-06
754 ALPHA BETA T CELL ACTIVATION 21 54 2.437e-07 1.504e-06
755 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 35 122 2.449e-07 1.509e-06
756 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 15 30 2.553e-07 1.569e-06
757 RESPONSE TO X RAY 15 30 2.553e-07 1.569e-06
758 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 34 117 2.586e-07 1.587e-06
759 REGULATION OF BMP SIGNALING PATHWAY 26 77 2.611e-07 1.6e-06
760 FACE DEVELOPMENT 20 50 2.731e-07 1.665e-06
761 STAT CASCADE 20 50 2.731e-07 1.665e-06
762 JAK STAT CASCADE 20 50 2.731e-07 1.665e-06
763 RESPONSE TO PROGESTERONE 20 50 2.731e-07 1.665e-06
764 NEGATIVE REGULATION OF DEFENSE RESPONSE 39 144 2.748e-07 1.674e-06
765 KIDNEY MORPHOGENESIS 27 82 2.768e-07 1.684e-06
766 REGULATION OF INTERFERON GAMMA PRODUCTION 30 97 2.92e-07 1.774e-06
767 HEART VALVE DEVELOPMENT 16 34 2.954e-07 1.792e-06
768 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 19 46 2.975e-07 1.802e-06
769 REGULATION OF ADAPTIVE IMMUNE RESPONSE 35 123 3.044e-07 1.84e-06
770 POSITIVE REGULATION OF MITOTIC CELL CYCLE 35 123 3.044e-07 1.84e-06
771 REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 17 38 3.135e-07 1.892e-06
772 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 34 118 3.23e-07 1.945e-06
773 NEGATIVE REGULATION OF ANOIKIS 11 17 3.23e-07 1.945e-06
774 PROTEIN DEPHOSPHORYLATION 47 190 3.359e-07 2.019e-06
775 REGULATION OF STEM CELL DIFFERENTIATION 33 113 3.401e-07 2.042e-06
776 RENAL TUBULE DEVELOPMENT 26 78 3.486e-07 2.09e-06
777 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 21 55 3.513e-07 2.098e-06
778 REGULATION OF KIDNEY DEVELOPMENT 21 55 3.513e-07 2.098e-06
779 REGULATION OF ION TRANSPORT 110 592 3.505e-07 2.098e-06
780 DEPHOSPHORYLATION 63 286 3.591e-07 2.142e-06
781 POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 14 27 3.612e-07 2.152e-06
782 RESPONSE TO LIGHT STIMULUS 62 280 3.663e-07 2.179e-06
783 OVULATION CYCLE PROCESS 28 88 3.745e-07 2.226e-06
784 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 29 93 3.774e-07 2.24e-06
785 DIVALENT INORGANIC CATION HOMEOSTASIS 72 343 3.944e-07 2.338e-06
786 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 20 51 4.004e-07 2.37e-06
787 T CELL RECEPTOR SIGNALING PATHWAY 39 146 4.055e-07 2.398e-06
788 NEGATIVE REGULATION OF CELL DIVISION 22 60 4.248e-07 2.505e-06
789 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 22 60 4.248e-07 2.505e-06
790 LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 15 31 4.415e-07 2.6e-06
791 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 19 47 4.451e-07 2.618e-06
792 RESPONSE TO TUMOR NECROSIS FACTOR 54 233 4.506e-07 2.647e-06
793 REGULATION OF INNATE IMMUNE RESPONSE 74 357 4.575e-07 2.685e-06
794 RESPONSE TO CAMP 31 104 4.647e-07 2.723e-06
795 LIPID PHOSPHORYLATION 30 99 4.78e-07 2.798e-06
796 REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 18 43 4.794e-07 2.802e-06
797 POST EMBRYONIC DEVELOPMENT 28 89 4.863e-07 2.839e-06
798 ANATOMICAL STRUCTURE MATURATION 17 39 4.956e-07 2.883e-06
799 REGULATION OF GRANULOCYTE CHEMOTAXIS 17 39 4.956e-07 2.883e-06
800 EMBRYO IMPLANTATION 17 39 4.956e-07 2.883e-06
801 ION HOMEOSTASIS 107 576 5.121e-07 2.975e-06
802 MUSCLE ORGAN DEVELOPMENT 61 277 5.53e-07 3.208e-06
803 RESPONSE TO UV 35 126 5.738e-07 3.325e-06
804 REGULATION OF MULTI ORGANISM PROCESS 91 470 5.825e-07 3.371e-06
805 SKIN DEVELOPMENT 50 211 5.857e-07 3.385e-06
806 RESPONSE TO TRANSITION METAL NANOPARTICLE 39 148 5.926e-07 3.417e-06
807 MALE SEX DIFFERENTIATION 39 148 5.926e-07 3.417e-06
808 POSITIVE REGULATION OF INTERLEUKIN 2 BIOSYNTHETIC PROCESS 9 12 6.027e-07 3.471e-06
809 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 30 100 6.076e-07 3.491e-06
810 PEPTIDYL TYROSINE DEPHOSPHORYLATION 30 100 6.076e-07 3.491e-06
811 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 29 95 6.22e-07 3.569e-06
812 CARDIAC SEPTUM DEVELOPMENT 27 85 6.248e-07 3.58e-06
813 CELL CYCLE ARREST 40 154 6.418e-07 3.673e-06
814 POSITIVE REGULATION OF CELL DIVISION 36 132 6.482e-07 3.701e-06
815 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 36 132 6.482e-07 3.701e-06
816 RESPONSE TO AXON INJURY 19 48 6.567e-07 3.744e-06
817 REGULATION OF HORMONE LEVELS 92 478 6.633e-07 3.778e-06
818 POSITIVE REGULATION OF LIPASE ACTIVITY 23 66 6.691e-07 3.801e-06
819 REGULATION OF CARDIAC MUSCLE CONTRACTION 23 66 6.691e-07 3.801e-06
820 REGULATION OF MITOCHONDRION ORGANIZATION 51 218 6.88e-07 3.904e-06
821 NEGATIVE REGULATION OF GROWTH 54 236 6.921e-07 3.923e-06
822 EXOCYTOSIS 66 310 7.009e-07 3.968e-06
823 POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 21 57 7.064e-07 3.994e-06
824 MYELOID CELL DEVELOPMENT 18 44 7.233e-07 4.074e-06
825 NEGATIVE REGULATION OF JAK STAT CASCADE 18 44 7.233e-07 4.074e-06
826 NEGATIVE REGULATION OF STAT CASCADE 18 44 7.233e-07 4.074e-06
827 ENDOCARDIAL CUSHION DEVELOPMENT 15 32 7.417e-07 4.165e-06
828 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 15 32 7.417e-07 4.165e-06
829 REGULATION OF INTERLEUKIN 2 BIOSYNTHETIC PROCESS 11 18 7.429e-07 4.165e-06
830 POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION 11 18 7.429e-07 4.165e-06
831 RESPIRATORY BURST 10 15 7.607e-07 4.259e-06
832 EXTRACELLULAR MATRIX DISASSEMBLY 25 76 7.733e-07 4.325e-06
833 POSITIVE REGULATION OF ERBB SIGNALING PATHWAY 16 36 7.795e-07 4.354e-06
834 POSITIVE REGULATION OF CYTOKINE SECRETION 29 96 7.932e-07 4.425e-06
835 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 26 81 7.998e-07 4.457e-06
836 POSITIVE REGULATION OF B CELL ACTIVATION 27 86 8.106e-07 4.512e-06
837 REGULATION OF SMOOTHENED SIGNALING PATHWAY 22 62 8.172e-07 4.543e-06
838 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 20 53 8.298e-07 4.602e-06
839 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 20 53 8.298e-07 4.602e-06
840 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 35 128 8.625e-07 4.778e-06
841 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 40 156 9.197e-07 5.089e-06
842 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 30 102 9.696e-07 5.352e-06
843 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 30 102 9.696e-07 5.352e-06
844 ENDOTHELIAL CELL DIFFERENTIATION 24 72 9.749e-07 5.375e-06
845 REGULATION OF INTERLEUKIN 1 PRODUCTION 21 58 9.866e-07 5.433e-06
846 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 29 97 1.007e-06 5.538e-06
847 JNK CASCADE 26 82 1.043e-06 5.726e-06
848 NEGATIVE REGULATION OF CATABOLIC PROCESS 48 203 1.044e-06 5.726e-06
849 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 79 397 1.056e-06 5.786e-06
850 CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS 43 174 1.074e-06 5.877e-06
851 EXOCRINE SYSTEM DEVELOPMENT 18 45 1.075e-06 5.877e-06
852 REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 14 29 1.114e-06 6.068e-06
853 POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 14 29 1.114e-06 6.068e-06
854 STEM CELL DIVISION 14 29 1.114e-06 6.068e-06
855 VASCULAR PROCESS IN CIRCULATORY SYSTEM 41 163 1.16e-06 6.315e-06
856 REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 17 41 1.171e-06 6.367e-06
857 DENDRITIC CELL DIFFERENTIATION 15 33 1.214e-06 6.571e-06
858 REGULATION OF MUSCLE TISSUE DEVELOPMENT 30 103 1.217e-06 6.571e-06
859 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 15 33 1.214e-06 6.571e-06
860 REGULATION OF CALCIUM ION IMPORT 30 103 1.217e-06 6.571e-06
861 RESPONSE TO DEXAMETHASONE 15 33 1.214e-06 6.571e-06
862 REGULATION OF MUSCLE ORGAN DEVELOPMENT 30 103 1.217e-06 6.571e-06
863 SOMATIC STEM CELL DIVISION 12 22 1.24e-06 6.686e-06
864 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 33 119 1.244e-06 6.699e-06
865 LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 29 98 1.273e-06 6.846e-06
866 ERYTHROCYTE HOMEOSTASIS 24 73 1.293e-06 6.95e-06
867 REGULATION OF ENDOTHELIAL CELL MIGRATION 32 114 1.34e-06 7.193e-06
868 REGULATION OF STEM CELL PROLIFERATION 27 88 1.344e-06 7.203e-06
869 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 72 354 1.363e-06 7.297e-06
870 RESPONSE TO INSULIN 48 205 1.408e-06 7.53e-06
871 MICROTUBULE CYTOSKELETON ORGANIZATION 71 348 1.43e-06 7.639e-06
872 NEGATIVE REGULATION OF PROTEOLYSIS 68 329 1.467e-06 7.83e-06
873 DNA REPAIR 91 480 1.49e-06 7.941e-06
874 FC EPSILON RECEPTOR SIGNALING PATHWAY 37 142 1.532e-06 8.154e-06
875 NEGATIVE REGULATION OF DNA BINDING 18 46 1.575e-06 8.364e-06
876 PEPTIDYL THREONINE MODIFICATION 18 46 1.575e-06 8.364e-06
877 DEVELOPMENTAL PROGRAMMED CELL DEATH 13 26 1.633e-06 8.655e-06
878 REGULATION OF T HELPER CELL DIFFERENTIATION 13 26 1.633e-06 8.655e-06
879 NEGATIVE REGULATION OF DNA REPLICATION 20 55 1.645e-06 8.708e-06
880 NEURAL TUBE FORMATION 28 94 1.668e-06 8.821e-06
881 RESPONSE TO ALKALOID 36 137 1.701e-06 8.965e-06
882 CELLULAR RESPONSE TO RADIATION 36 137 1.701e-06 8.965e-06
883 ACTIVATION OF MAPK ACTIVITY 36 137 1.701e-06 8.965e-06
884 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 24 74 1.705e-06 8.973e-06
885 DENDRITE DEVELOPMENT 25 79 1.74e-06 9.15e-06
886 REGULATION OF MITOPHAGY 17 42 1.755e-06 9.218e-06
887 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 10 16 1.816e-06 9.527e-06
888 SMOOTH MUSCLE CELL DIFFERENTIATION 14 30 1.865e-06 9.77e-06
889 DNA BIOSYNTHETIC PROCESS 33 121 1.867e-06 9.773e-06
890 STEM CELL PROLIFERATION 21 60 1.871e-06 9.782e-06
891 MAINTENANCE OF CELL NUMBER 35 132 1.883e-06 9.832e-06
892 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 16 38 1.889e-06 9.841e-06
893 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 16 38 1.889e-06 9.841e-06
894 HOMOTYPIC CELL CELL ADHESION 19 51 1.953e-06 1.017e-05
895 CELL CELL SIGNALING 132 767 1.983e-06 1.031e-05
896 POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION 22 65 2.045e-06 1.062e-05
897 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 28 95 2.106e-06 1.092e-05
898 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 52 232 2.126e-06 1.102e-05
899 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 23 70 2.165e-06 1.12e-05
900 ENDOTHELIUM DEVELOPMENT 27 90 2.184e-06 1.126e-05
901 REGULATION OF GLIOGENESIS 27 90 2.184e-06 1.126e-05
902 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 48 208 2.182e-06 1.126e-05
903 CELLULAR GLUCOSE HOMEOSTASIS 24 75 2.233e-06 1.151e-05
904 TOLL LIKE RECEPTOR SIGNALING PATHWAY 26 85 2.235e-06 1.151e-05
905 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 25 80 2.254e-06 1.159e-05
906 RESPONSE TO INCREASED OXYGEN LEVELS 12 23 2.318e-06 1.189e-05
907 RESPONSE TO HYPEROXIA 12 23 2.318e-06 1.189e-05
908 MEMBRANE ORGANIZATION 150 899 2.481e-06 1.271e-05
909 REGULATION OF HEART CONTRACTION 50 221 2.491e-06 1.275e-05
910 HEPATICOBILIARY SYSTEM DEVELOPMENT 34 128 2.514e-06 1.285e-05
911 EMBRYONIC DIGIT MORPHOGENESIS 21 61 2.543e-06 1.299e-05
912 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 40 162 2.571e-06 1.312e-05
913 POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 19 52 2.744e-06 1.398e-05
914 VIRAL LIFE CYCLE 61 290 2.761e-06 1.405e-05
915 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 13 27 2.814e-06 1.425e-05
916 CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 13 27 2.814e-06 1.425e-05
917 AXIS ELONGATION 13 27 2.814e-06 1.425e-05
918 REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE 13 27 2.814e-06 1.425e-05
919 REGULATION OF NEUTROPHIL CHEMOTAXIS 13 27 2.814e-06 1.425e-05
920 REGULATION OF AXON GUIDANCE 16 39 2.858e-06 1.442e-05
921 ENDODERM DEVELOPMENT 23 71 2.852e-06 1.442e-05
922 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 16 39 2.858e-06 1.442e-05
923 ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE 72 361 2.866e-06 1.445e-05
924 AMINOGLYCAN BIOSYNTHETIC PROCESS 30 107 2.912e-06 1.465e-05
925 PLATELET DEGRANULATION 30 107 2.912e-06 1.465e-05
926 CELLULAR COMPONENT DISASSEMBLY 95 515 3.008e-06 1.511e-05
927 NUCLEAR TRANSPORT 71 355 3.023e-06 1.517e-05
928 RESPONSE TO MINERALOCORTICOID 15 35 3.029e-06 1.517e-05
929 B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 15 35 3.029e-06 1.517e-05
930 RESPONSE TO VIRUS 54 247 3.041e-06 1.521e-05
931 RESPONSE TO PROTOZOAN 11 20 3.138e-06 1.568e-05
932 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 18 48 3.247e-06 1.621e-05
933 DEVELOPMENTAL MATURATION 45 193 3.342e-06 1.666e-05
934 REGULATION OF DEPHOSPHORYLATION 39 158 3.441e-06 1.714e-05
935 INNER EAR MORPHOGENESIS 27 92 3.483e-06 1.733e-05
936 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 30 108 3.588e-06 1.784e-05
937 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 26 87 3.623e-06 1.785e-05
938 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 26 87 3.623e-06 1.785e-05
939 POSITIVE REGULATION OF ION TRANSPORT 52 236 3.617e-06 1.785e-05
940 VIRAL ENTRY INTO HOST CELL 26 87 3.623e-06 1.785e-05
941 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 26 87 3.623e-06 1.785e-05
942 REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 22 67 3.625e-06 1.785e-05
943 MOVEMENT IN HOST ENVIRONMENT 26 87 3.623e-06 1.785e-05
944 ENTRY INTO HOST 26 87 3.623e-06 1.785e-05
945 ENTRY INTO HOST CELL 26 87 3.623e-06 1.785e-05
946 GLUCOSE HOMEOSTASIS 41 170 3.666e-06 1.801e-05
947 CARBOHYDRATE HOMEOSTASIS 41 170 3.666e-06 1.801e-05
948 BODY MORPHOGENESIS 17 44 3.765e-06 1.848e-05
949 MESONEPHRIC TUBULE MORPHOGENESIS 19 53 3.813e-06 1.87e-05
950 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 29 103 3.863e-06 1.892e-05
951 NEGATIVE REGULATION OF SECRETION 46 200 3.873e-06 1.895e-05
952 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 38 153 3.9e-06 1.906e-05
953 IMMUNOLOGICAL SYNAPSE FORMATION 8 11 3.919e-06 1.913e-05
954 POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 10 17 3.949e-06 1.926e-05
955 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 12 24 4.145e-06 2.02e-05
956 POSITIVE REGULATION OF CELL MATRIX ADHESION 16 40 4.251e-06 2.069e-05
957 REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS 41 171 4.287e-06 2.082e-05
958 REGULATION OF RESPONSE TO NUTRIENT LEVELS 41 171 4.287e-06 2.082e-05
959 REGULATION OF MICROVILLUS ORGANIZATION 9 14 4.405e-06 2.131e-05
960 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 9 14 4.405e-06 2.131e-05
961 POSITIVE REGULATION OF B CELL DIFFERENTIATION 9 14 4.405e-06 2.131e-05
962 POST EMBRYONIC ORGAN DEVELOPMENT 9 14 4.405e-06 2.131e-05
963 LEUKOCYTE MEDIATED IMMUNITY 44 189 4.457e-06 2.154e-05
964 POSITIVE REGULATION OF JUN KINASE ACTIVITY 21 63 4.581e-06 2.211e-05
965 REGULATION OF ERYTHROCYTE DIFFERENTIATION 15 36 4.635e-06 2.23e-05
966 SEMAPHORIN PLEXIN SIGNALING PATHWAY 15 36 4.635e-06 2.23e-05
967 CORTICAL CYTOSKELETON ORGANIZATION 15 36 4.635e-06 2.23e-05
968 REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 13 28 4.694e-06 2.254e-05
969 RESPONSE TO COPPER ION 13 28 4.694e-06 2.254e-05
970 ORGAN GROWTH 22 68 4.775e-06 2.286e-05
971 REGULATION OF PHAGOCYTOSIS 22 68 4.775e-06 2.286e-05
972 AMINOGLYCAN CATABOLIC PROCESS 22 68 4.775e-06 2.286e-05
973 SALIVARY GLAND DEVELOPMENT 14 32 4.822e-06 2.303e-05
974 REGULATION OF NEUTROPHIL MIGRATION 14 32 4.822e-06 2.303e-05
975 POSITIVE REGULATION OF STAT CASCADE 23 73 4.856e-06 2.313e-05
976 POSITIVE REGULATION OF JAK STAT CASCADE 23 73 4.856e-06 2.313e-05
977 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 23 73 4.856e-06 2.313e-05
978 AMINOGLYCAN METABOLIC PROCESS 40 166 4.901e-06 2.332e-05
979 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 19 54 5.246e-06 2.493e-05
980 ALPHA BETA T CELL DIFFERENTIATION 17 45 5.398e-06 2.563e-05
981 NEGATIVE REGULATION OF IMMUNE RESPONSE 32 121 5.423e-06 2.572e-05
982 REGULATION OF PROTEIN STABILITY 49 221 5.68e-06 2.692e-05
983 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 40 167 5.732e-06 2.713e-05
984 VASCULOGENESIS 20 59 5.746e-06 2.717e-05
985 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 53 246 5.869e-06 2.773e-05
986 MAST CELL ACTIVATION 11 21 5.896e-06 2.779e-05
987 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 11 21 5.896e-06 2.779e-05
988 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 45 197 5.945e-06 2.8e-05
989 REGULATION OF STRIATED MUSCLE CONTRACTION 24 79 6.191e-06 2.913e-05
990 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 16 41 6.221e-06 2.918e-05
991 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 16 41 6.221e-06 2.918e-05
992 LUNG ALVEOLUS DEVELOPMENT 16 41 6.221e-06 2.918e-05
993 NEGATIVE REGULATION OF OSSIFICATION 22 69 6.247e-06 2.927e-05
994 LIMBIC SYSTEM DEVELOPMENT 28 100 6.333e-06 2.965e-05
995 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 18 50 6.379e-06 2.983e-05
996 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 40 168 6.69e-06 3.126e-05
997 ACTIVATION OF INNATE IMMUNE RESPONSE 46 204 6.782e-06 3.165e-05
998 POSITIVE REGULATION OF B CELL PROLIFERATION 15 37 6.96e-06 3.238e-05
999 RESPONSE TO NERVE GROWTH FACTOR 15 37 6.96e-06 3.238e-05
1000 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 15 37 6.96e-06 3.238e-05
1001 MUSCLE CELL DEVELOPMENT 33 128 7.05e-06 3.277e-05
1002 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 12 25 7.128e-06 3.31e-05
1003 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 19 55 7.146e-06 3.315e-05
1004 RESPONSE TO VITAMIN D 14 33 7.48e-06 3.466e-05
1005 POSITIVE REGULATION OF MULTI ORGANISM PROCESS 38 157 7.486e-06 3.466e-05
1006 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 13 29 7.604e-06 3.517e-05
1007 SINGLE ORGANISM BEHAVIOR 74 384 7.634e-06 3.526e-05
1008 CATABOLIC PROCESS 264 1773 7.639e-06 3.526e-05
1009 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 20 60 7.684e-06 3.543e-05
1010 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 10 18 7.957e-06 3.666e-05
1011 RESPONSE TO AMINO ACID 30 112 7.994e-06 3.675e-05
1012 NEGATIVE REGULATION OF AXONOGENESIS 21 65 8e-06 3.675e-05
1013 ZYMOGEN ACTIVATION 30 112 7.994e-06 3.675e-05
1014 REGULATED EXOCYTOSIS 49 224 8.4e-06 3.855e-05
1015 NUCLEAR IMPORT 33 129 8.429e-06 3.864e-05
1016 RENAL SYSTEM PROCESS 28 102 9.572e-06 4.384e-05
1017 METANEPHROS DEVELOPMENT 24 81 9.972e-06 4.562e-05
1018 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 15 38 1.027e-05 4.693e-05
1019 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 21 66 1.046e-05 4.766e-05
1020 MESODERM MORPHOGENESIS 21 66 1.046e-05 4.766e-05
1021 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 21 66 1.046e-05 4.766e-05
1022 SKIN EPIDERMIS DEVELOPMENT 22 71 1.048e-05 4.772e-05
1023 NATURAL KILLER CELL DIFFERENTIATION 8 12 1.055e-05 4.776e-05
1024 POSITIVE REGULATION OF CELLULAR EXTRAVASATION 8 12 1.055e-05 4.776e-05
1025 ENDOCARDIAL CUSHION MORPHOGENESIS 11 22 1.055e-05 4.776e-05
1026 CELL ADHESION MEDIATED BY INTEGRIN 8 12 1.055e-05 4.776e-05
1027 REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 11 22 1.055e-05 4.776e-05
1028 EMBRYONIC PLACENTA MORPHOGENESIS 11 22 1.055e-05 4.776e-05
1029 POSITIVE REGULATION OF DEPHOSPHORYLATION 17 47 1.068e-05 4.828e-05
1030 COGNITION 53 251 1.078e-05 4.868e-05
1031 T CELL HOMEOSTASIS 14 34 1.136e-05 5.122e-05
1032 PROTEIN KINASE B SIGNALING 14 34 1.136e-05 5.122e-05
1033 RESPONSE TO TEMPERATURE STIMULUS 36 148 1.143e-05 5.147e-05
1034 ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 37 154 1.173e-05 5.278e-05
1035 REPLACEMENT OSSIFICATION 12 26 1.184e-05 5.306e-05
1036 ENDOCHONDRAL OSSIFICATION 12 26 1.184e-05 5.306e-05
1037 MYELOID DENDRITIC CELL ACTIVATION 12 26 1.184e-05 5.306e-05
1038 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 12 26 1.184e-05 5.306e-05
1039 POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 44 196 1.198e-05 5.367e-05
1040 CELLULAR RESPONSE TO IONIZING RADIATION 18 52 1.2e-05 5.367e-05
1041 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 39 166 1.211e-05 5.412e-05
1042 PROTEIN MATURATION 55 265 1.257e-05 5.613e-05
1043 PROTEIN LOCALIZATION TO MEMBRANE 72 376 1.262e-05 5.631e-05
1044 REGULATION OF DENDRITE DEVELOPMENT 31 120 1.263e-05 5.631e-05
1045 NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 16 43 1.275e-05 5.677e-05
1046 REGULATION OF PEPTIDE SECRETION 46 209 1.324e-05 5.889e-05
1047 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 45 203 1.35e-05 5.999e-05
1048 POSITIVE REGULATION OF NEURON DEATH 21 67 1.358e-05 6.028e-05
1049 POSITIVE REGULATION OF BLOOD CIRCULATION 26 93 1.38e-05 6.12e-05
1050 REGULATION OF COAGULATION 25 88 1.481e-05 6.555e-05
1051 MAINTENANCE OF LOCATION 34 138 1.48e-05 6.555e-05
1052 NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 15 39 1.49e-05 6.583e-05
1053 CELLULAR RESPONSE TO NUTRIENT 15 39 1.49e-05 6.583e-05
1054 PROSTAGLANDIN BIOSYNTHETIC PROCESS 10 19 1.504e-05 6.622e-05
1055 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 10 19 1.504e-05 6.622e-05
1056 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 10 19 1.504e-05 6.622e-05
1057 PROSTANOID BIOSYNTHETIC PROCESS 10 19 1.504e-05 6.622e-05
1058 ORGANOPHOSPHATE METABOLIC PROCESS 144 885 1.519e-05 6.681e-05
1059 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 27 99 1.561e-05 6.854e-05
1060 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 27 99 1.561e-05 6.854e-05
1061 HAIR CYCLE 24 83 1.574e-05 6.896e-05
1062 MOLTING CYCLE 24 83 1.574e-05 6.896e-05
1063 NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 37 156 1.598e-05 6.989e-05
1064 PROTEIN LOCALIZATION TO NUCLEUS 37 156 1.598e-05 6.989e-05
1065 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 57 280 1.605e-05 7.014e-05
1066 POSITIVE REGULATION OF RESPONSE TO WOUNDING 38 162 1.618e-05 7.06e-05
1067 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 18 53 1.62e-05 7.066e-05
1068 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 14 35 1.691e-05 7.369e-05
1069 POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 22 73 1.716e-05 7.468e-05
1070 REGULATION OF EPIDERMIS DEVELOPMENT 20 63 1.752e-05 7.612e-05
1071 RESPONSE TO OSMOTIC STRESS 20 63 1.752e-05 7.612e-05
1072 NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 16 44 1.788e-05 7.763e-05
1073 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 11 23 1.81e-05 7.826e-05
1074 ADRENAL GLAND DEVELOPMENT 11 23 1.81e-05 7.826e-05
1075 LEUKOCYTE APOPTOTIC PROCESS 11 23 1.81e-05 7.826e-05
1076 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 11 23 1.81e-05 7.826e-05
1077 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 43 193 1.822e-05 7.873e-05
1078 EPITHELIAL CELL PROLIFERATION 25 89 1.834e-05 7.917e-05
1079 POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 29 111 1.887e-05 8.136e-05
1080 MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM 27 100 1.905e-05 8.164e-05
1081 POSITIVE REGULATION OF NEUTROPHIL MIGRATION 12 27 1.906e-05 8.164e-05
1082 PROSTAGLANDIN METABOLIC PROCESS 12 27 1.906e-05 8.164e-05
1083 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 32 128 1.901e-05 8.164e-05
1084 INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 12 27 1.906e-05 8.164e-05
1085 PROSTANOID METABOLIC PROCESS 12 27 1.906e-05 8.164e-05
1086 POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 12 27 1.906e-05 8.164e-05
1087 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 24 84 1.963e-05 8.403e-05
1088 NOTCH RECEPTOR PROCESSING 9 16 2.023e-05 8.619e-05
1089 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 17 49 2.016e-05 8.619e-05
1090 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 9 16 2.023e-05 8.619e-05
1091 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 9 16 2.023e-05 8.619e-05
1092 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 9 16 2.023e-05 8.619e-05
1093 NON CANONICAL WNT SIGNALING PATHWAY 34 140 2.049e-05 8.721e-05
1094 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 18 54 2.168e-05 9.206e-05
1095 VENTRICULAR SEPTUM DEVELOPMENT 18 54 2.168e-05 9.206e-05
1096 POSITIVE REGULATION OF CALCIUM ION IMPORT 18 54 2.168e-05 9.206e-05
1097 NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 21 69 2.244e-05 9.517e-05
1098 POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 20 64 2.272e-05 9.63e-05
1099 ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE 54 264 2.306e-05 9.761e-05
1100 CAMERA TYPE EYE MORPHOGENESIS 27 101 2.315e-05 9.793e-05
1101 REGULATION OF CHROMOSOME SEGREGATION 24 85 2.437e-05 0.0001029
1102 HEART PROCESS 24 85 2.437e-05 0.0001029
1103 REGULATION OF HISTONE PHOSPHORYLATION 8 13 2.462e-05 0.0001038
1104 SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE 8 13 2.462e-05 0.0001038
1105 POSITIVE REGULATION OF AXON EXTENSION 14 36 2.473e-05 0.0001039
1106 POSITIVE REGULATION OF PROTEIN ACETYLATION 14 36 2.473e-05 0.0001039
1107 HEAD MORPHOGENESIS 14 36 2.473e-05 0.0001039
1108 PROTEIN LOCALIZATION TO CHROMOSOME 16 45 2.477e-05 0.000104
1109 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 10 20 2.695e-05 0.0001124
1110 POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION 10 20 2.695e-05 0.0001124
1111 CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 10 20 2.695e-05 0.0001124
1112 RELAXATION OF MUSCLE 10 20 2.695e-05 0.0001124
1113 RESPONSE TO VITAMIN A 10 20 2.695e-05 0.0001124
1114 LYMPH VESSEL DEVELOPMENT 10 20 2.695e-05 0.0001124
1115 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 10 20 2.695e-05 0.0001124
1116 MYELOID DENDRITIC CELL DIFFERENTIATION 10 20 2.695e-05 0.0001124
1117 ENDODERM FORMATION 17 50 2.726e-05 0.0001134
1118 REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 17 50 2.726e-05 0.0001134
1119 RESPONSE TO ETHANOL 33 136 2.744e-05 0.000114
1120 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 22 75 2.745e-05 0.000114
1121 NEGATIVE REGULATION OF LEUKOCYTE MIGRATION 13 32 2.779e-05 0.0001151
1122 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 13 32 2.779e-05 0.0001151
1123 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 13 32 2.779e-05 0.0001151
1124 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 13 32 2.779e-05 0.0001151
1125 REGULATION OF MEMBRANE PERMEABILITY 21 70 2.858e-05 0.0001182
1126 REGULATION OF SMOOTH MUSCLE CONTRACTION 19 60 2.938e-05 0.0001214
1127 TELENCEPHALON DEVELOPMENT 48 228 2.975e-05 0.0001228
1128 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 12 28 2.983e-05 0.0001229
1129 MITOTIC SPINDLE ASSEMBLY 15 41 2.998e-05 0.0001229
1130 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 11 24 2.99e-05 0.0001229
1131 MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS 15 41 2.998e-05 0.0001229
1132 MITOTIC RECOMBINATION 15 41 2.998e-05 0.0001229
1133 REGULATION OF LEUKOCYTE DEGRANULATION 15 41 2.998e-05 0.0001229
1134 PROSTATE GLAND DEVELOPMENT 15 41 2.998e-05 0.0001229
1135 LACTATION 15 41 2.998e-05 0.0001229
1136 NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 32 131 3.129e-05 0.0001281
1137 HINDBRAIN DEVELOPMENT 33 137 3.217e-05 0.0001316
1138 DNA GEOMETRIC CHANGE 23 81 3.237e-05 0.0001323
1139 SINGLE ORGANISM BIOSYNTHETIC PROCESS 203 1340 3.288e-05 0.0001343
1140 REGULATION OF CELL PROJECTION ASSEMBLY 36 155 3.346e-05 0.0001366
1141 NEGATIVE REGULATION OF NUCLEAR DIVISION 16 46 3.391e-05 0.0001383
1142 MITOCHONDRIAL MEMBRANE ORGANIZATION 25 92 3.399e-05 0.0001385
1143 PURINE CONTAINING COMPOUND METABOLIC PROCESS 73 394 3.488e-05 0.000142
1144 GLIAL CELL MIGRATION 14 37 3.554e-05 0.0001446
1145 INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 21 71 3.617e-05 0.0001469
1146 ADHERENS JUNCTION ORGANIZATION 21 71 3.617e-05 0.0001469
1147 PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 28 109 3.639e-05 0.0001476
1148 NEGATIVE REGULATION OF CHEMOTAXIS 17 51 3.649e-05 0.0001478
1149 CELLULAR RESPONSE TO FATTY ACID 17 51 3.649e-05 0.0001478
1150 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 18 56 3.781e-05 0.000153
1151 POSITIVE REGULATION OF STEM CELL PROLIFERATION 19 61 3.806e-05 0.0001539
1152 DENDRITIC SPINE ORGANIZATION 9 17 3.854e-05 0.0001555
1153 MATURE B CELL DIFFERENTIATION 9 17 3.854e-05 0.0001555
1154 MACROMOLECULAR COMPLEX ASSEMBLY 210 1398 4.067e-05 0.000164
1155 SOMATIC CELL DNA RECOMBINATION 13 33 4.1e-05 0.0001644
1156 REGULATION OF T CELL APOPTOTIC PROCESS 13 33 4.1e-05 0.0001644
1157 POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 13 33 4.1e-05 0.0001644
1158 SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA GERMLINE RECOMBINATION WITHIN A SINGLE LOCUS 13 33 4.1e-05 0.0001644
1159 REGULATION OF BONE RESORPTION 13 33 4.1e-05 0.0001644
1160 EMBRYONIC EYE MORPHOGENESIS 13 33 4.1e-05 0.0001644
1161 PITUITARY GLAND DEVELOPMENT 15 42 4.165e-05 0.0001666
1162 DENDRITE MORPHOGENESIS 15 42 4.165e-05 0.0001666
1163 REGULATION OF BONE REMODELING 15 42 4.165e-05 0.0001666
1164 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 24 88 4.54e-05 0.0001815
1165 REGULATION OF HEART MORPHOGENESIS 12 29 4.551e-05 0.0001815
1166 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 12 29 4.551e-05 0.0001815
1167 RESPONSE TO DSRNA 21 72 4.553e-05 0.0001815
1168 NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 16 47 4.591e-05 0.0001826
1169 THYMUS DEVELOPMENT 16 47 4.591e-05 0.0001826
1170 RESPONSE TO ANTIBIOTIC 16 47 4.591e-05 0.0001826
1171 B CELL HOMEOSTASIS 10 21 4.609e-05 0.000183
1172 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 10 21 4.609e-05 0.000183
1173 REGULATION OF SISTER CHROMATID SEGREGATION 20 67 4.76e-05 0.0001888
1174 SPINDLE CHECKPOINT 11 25 4.78e-05 0.0001893
1175 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 11 25 4.78e-05 0.0001893
1176 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 17 52 4.838e-05 0.0001913
1177 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 17 52 4.838e-05 0.0001913
1178 CYCLIC NUCLEOTIDE METABOLIC PROCESS 18 57 4.93e-05 0.0001947
1179 SISTER CHROMATID SEGREGATION 39 176 4.962e-05 0.0001958
1180 BEHAVIOR 90 516 5.007e-05 0.0001974
1181 REGULATION OF SYNAPTIC PLASTICITY 33 140 5.114e-05 0.0002015
1182 POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 8 14 5.158e-05 0.000202
1183 SPECIFICATION OF ORGAN IDENTITY 8 14 5.158e-05 0.000202
1184 CELLULAR RESPONSE TO INSULIN STIMULUS 34 146 5.155e-05 0.000202
1185 HORMONE MEDIATED SIGNALING PATHWAY 36 158 5.149e-05 0.000202
1186 METANEPHRIC MESENCHYME DEVELOPMENT 8 14 5.158e-05 0.000202
1187 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 8 14 5.158e-05 0.000202
1188 CONVERGENT EXTENSION 8 14 5.158e-05 0.000202
1189 MUSCLE CONTRACTION 48 233 5.298e-05 0.0002073
1190 CHROMOSOME SEGREGATION 54 272 5.419e-05 0.0002119
1191 SPECIFICATION OF SYMMETRY 29 117 5.424e-05 0.0002119
1192 POSITIVE REGULATION OF PROTEIN BINDING 21 73 5.699e-05 0.0002225
1193 MORPHOGENESIS OF AN EPITHELIAL SHEET 15 43 5.713e-05 0.0002228
1194 SPINAL CORD DEVELOPMENT 27 106 5.833e-05 0.0002271
1195 REGULATION OF FAT CELL DIFFERENTIATION 27 106 5.833e-05 0.0002271
1196 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 13 34 5.934e-05 0.0002307
1197 ORGAN FORMATION 13 34 5.934e-05 0.0002307
1198 CYTOKINESIS 23 84 6.066e-05 0.0002356
1199 BONE TRABECULA MORPHOGENESIS 7 11 6.113e-05 0.0002364
1200 POSITIVE REGULATION OF HORMONE METABOLIC PROCESS 7 11 6.113e-05 0.0002364
1201 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 7 11 6.113e-05 0.0002364
1202 LYMPHOID PROGENITOR CELL DIFFERENTIATION 7 11 6.113e-05 0.0002364
1203 CORPUS CALLOSUM DEVELOPMENT 7 11 6.113e-05 0.0002364
1204 REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 16 48 6.148e-05 0.0002374
1205 REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 16 48 6.148e-05 0.0002374
1206 NUCLEAR CHROMOSOME SEGREGATION 47 228 6.201e-05 0.0002393
1207 NEUROEPITHELIAL CELL DIFFERENTIATION 19 63 6.252e-05 0.0002408
1208 REGULATION OF MUSCLE ADAPTATION 19 63 6.252e-05 0.0002408
1209 NEURON PROJECTION EXTENSION 17 53 6.358e-05 0.0002445
1210 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 17 53 6.358e-05 0.0002445
1211 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 24 90 6.732e-05 0.0002586
1212 RESPONSE TO EPIDERMAL GROWTH FACTOR 12 30 6.786e-05 0.0002601
1213 RESPONSE TO GROWTH HORMONE 12 30 6.786e-05 0.0002601
1214 OSTEOCLAST DIFFERENTIATION 12 30 6.786e-05 0.0002601
1215 GLIAL CELL DIFFERENTIATION 32 136 6.842e-05 0.000262
1216 REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS 9 18 6.913e-05 0.0002639
1217 KIDNEY MESENCHYME DEVELOPMENT 9 18 6.913e-05 0.0002639
1218 LYMPHOCYTE APOPTOTIC PROCESS 9 18 6.913e-05 0.0002639
1219 UTERUS DEVELOPMENT 9 18 6.913e-05 0.0002639
1220 BASE EXCISION REPAIR 14 39 7.01e-05 0.0002674
1221 SMALL MOLECULE METABOLIC PROCESS 256 1767 7.347e-05 0.00028
1222 MESODERMAL CELL DIFFERENTIATION 11 26 7.417e-05 0.000282
1223 REGULATION OF HORMONE METABOLIC PROCESS 11 26 7.417e-05 0.000282
1224 POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 23 85 7.412e-05 0.000282
1225 GLUCOSE METABOLIC PROCESS 29 119 7.54e-05 0.0002864
1226 BONE CELL DEVELOPMENT 10 22 7.571e-05 0.0002866
1227 RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 10 22 7.571e-05 0.0002866
1228 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 10 22 7.571e-05 0.0002866
1229 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 10 22 7.571e-05 0.0002866
1230 POSITIVE REGULATION OF MUSCLE CONTRACTION 15 44 7.743e-05 0.0002927
1231 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 15 44 7.743e-05 0.0002927
1232 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 31 131 7.87e-05 0.000297
1233 LEARNING 31 131 7.87e-05 0.000297
1234 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 35 155 7.892e-05 0.0002976
1235 PROTEIN COMPLEX BIOGENESIS 173 1132 7.99e-05 0.0003008
1236 PROTEIN COMPLEX ASSEMBLY 173 1132 7.99e-05 0.0003008
1237 REGULATION OF STEROID BIOSYNTHETIC PROCESS 16 49 8.152e-05 0.0003066
1238 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 18 59 8.192e-05 0.0003079
1239 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 52 263 8.237e-05 0.0003093
1240 NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 13 35 8.441e-05 0.0003162
1241 BONE REMODELING 13 35 8.441e-05 0.0003162
1242 RESPONSE TO MONOAMINE 13 35 8.441e-05 0.0003162
1243 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 28 114 8.593e-05 0.0003217
1244 REGULATION OF DNA REPAIR 21 75 8.787e-05 0.0003286
1245 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 33 144 9.207e-05 0.0003441
1246 REGULATION OF CIRCADIAN RHYTHM 26 103 9.329e-05 0.0003484
1247 PROTEIN TARGETING 73 406 9.454e-05 0.0003528
1248 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 49 245 9.696e-05 0.0003615
1249 NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 27 109 9.771e-05 0.000364
1250 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 8 15 9.924e-05 0.0003685
1251 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 8 15 9.924e-05 0.0003685
1252 REGULATION OF PLATELET ACTIVATION 12 31 9.906e-05 0.0003685
1253 VENOUS BLOOD VESSEL DEVELOPMENT 8 15 9.924e-05 0.0003685
1254 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 19 65 9.999e-05 0.000371
1255 LUNG MORPHOGENESIS 15 45 0.0001038 0.0003835
1256 REGULATION OF EPIDERMAL CELL DIFFERENTIATION 15 45 0.0001038 0.0003835
1257 NEGATIVE REGULATION OF CHROMATIN MODIFICATION 15 45 0.0001038 0.0003835
1258 HEXOSE METABOLIC PROCESS 35 157 0.0001037 0.0003835
1259 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 15 45 0.0001038 0.0003835
1260 HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 25 98 0.0001051 0.0003882
1261 HISTONE H4 ACETYLATION 16 50 0.0001071 0.000395
1262 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 11 27 0.0001121 0.0004132
1263 INTRACELLULAR PROTEIN TRANSPORT 125 781 0.0001143 0.0004211
1264 DNA REPLICATION 43 208 0.0001164 0.0004286
1265 THYMIC T CELL SELECTION 9 19 0.0001178 0.0004312
1266 CELLULAR RESPONSE TO FLUID SHEAR STRESS 9 19 0.0001178 0.0004312
1267 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 9 19 0.0001178 0.0004312
1268 CELLULAR RESPONSE TO GAMMA RADIATION 9 19 0.0001178 0.0004312
1269 ACTIN FILAMENT BASED MOVEMENT 24 93 0.000118 0.0004312
1270 NEGATIVE REGULATION OF HISTONE MODIFICATION 13 36 0.0001181 0.0004312
1271 KIDNEY VASCULATURE DEVELOPMENT 9 19 0.0001178 0.0004312
1272 POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION 9 19 0.0001178 0.0004312
1273 LAMELLIPODIUM ORGANIZATION 13 36 0.0001181 0.0004312
1274 RENAL SYSTEM VASCULATURE DEVELOPMENT 9 19 0.0001178 0.0004312
1275 POSITIVE CHEMOTAXIS 13 36 0.0001181 0.0004312
1276 PROTEIN SECRETION 28 116 0.0001188 0.0004331
1277 POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 10 23 0.00012 0.0004373
1278 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 22 82 0.0001209 0.00044
1279 CELLULAR RESPONSE TO UV 19 66 0.0001253 0.0004555
1280 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 25 99 0.0001253 0.0004555
1281 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 53 274 0.0001279 0.0004644
1282 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 14 41 0.0001308 0.0004741
1283 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 14 41 0.0001308 0.0004741
1284 MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 14 41 0.0001308 0.0004741
1285 REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 18 61 0.0001322 0.0004769
1286 CELLULAR RESPONSE TO INTERLEUKIN 1 23 88 0.0001319 0.0004769
1287 REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 7 12 0.0001319 0.0004769
1288 REGULATION OF INTERLEUKIN 8 PRODUCTION 18 61 0.0001322 0.0004769
1289 MODULATION OF SYNAPTIC TRANSMISSION 57 301 0.000132 0.0004769
1290 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 7 12 0.0001319 0.0004769
1291 ACTOMYOSIN STRUCTURE ORGANIZATION 21 77 0.0001328 0.0004781
1292 DIENCEPHALON DEVELOPMENT 21 77 0.0001328 0.0004781
1293 REGULATION OF HISTONE METHYLATION 17 56 0.0001372 0.0004935
1294 ICOSANOID BIOSYNTHETIC PROCESS 15 46 0.0001375 0.0004935
1295 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 15 46 0.0001375 0.0004935
1296 POSITIVE REGULATION OF PHAGOCYTOSIS 15 46 0.0001375 0.0004935
1297 FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS 15 46 0.0001375 0.0004935
1298 PALLIUM DEVELOPMENT 34 153 0.000138 0.0004946
1299 REGULATION OF INTERLEUKIN 12 PRODUCTION 16 51 0.0001393 0.000499
1300 MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 12 32 0.0001418 0.0005064
1301 PROXIMAL DISTAL PATTERN FORMATION 12 32 0.0001418 0.0005064
1302 METANEPHRIC NEPHRON DEVELOPMENT 12 32 0.0001418 0.0005064
1303 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 12 32 0.0001418 0.0005064
1304 METENCEPHALON DEVELOPMENT 25 100 0.0001489 0.0005313
1305 SINGLE ORGANISM CATABOLIC PROCESS 148 957 0.0001498 0.0005342
1306 REGULATION OF TRANSMEMBRANE TRANSPORT 75 426 0.000152 0.0005415
1307 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 19 67 0.000156 0.0005555
1308 POSITIVE REGULATION OF PROTEIN POLYMERIZATION 23 89 0.0001585 0.0005639
1309 ORGANONITROGEN COMPOUND METABOLIC PROCESS 257 1796 0.0001609 0.0005721
1310 CORONARY VASCULATURE DEVELOPMENT 13 37 0.0001629 0.0005762
1311 HINDLIMB MORPHOGENESIS 13 37 0.0001629 0.0005762
1312 ACTIN POLYMERIZATION OR DEPOLYMERIZATION 13 37 0.0001629 0.0005762
1313 EPIDERMAL CELL DIFFERENTIATION 32 142 0.0001627 0.0005762
1314 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 13 37 0.0001629 0.0005762
1315 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 13 37 0.0001629 0.0005762
1316 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 43 211 0.000163 0.0005762
1317 VENTRICULAR SEPTUM MORPHOGENESIS 11 28 0.0001653 0.0005817
1318 NEGATIVE REGULATION OF CHROMOSOME SEGREGATION 11 28 0.0001653 0.0005817
1319 POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION 11 28 0.0001653 0.0005817
1320 REGULATION OF SPROUTING ANGIOGENESIS 11 28 0.0001653 0.0005817
1321 RESPONSE TO GONADOTROPIN 11 28 0.0001653 0.0005817
1322 METANEPHROS MORPHOGENESIS 11 28 0.0001653 0.0005817
1323 POSITIVE REGULATION OF NUCLEAR DIVISION 18 62 0.0001663 0.0005848
1324 SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS 14 42 0.0001754 0.0006164
1325 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 22 84 0.0001771 0.000622
1326 DENDRITIC CELL CHEMOTAXIS 8 16 0.0001783 0.0006227
1327 ASSOCIATIVE LEARNING 20 73 0.0001777 0.0006227
1328 NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 8 16 0.0001783 0.0006227
1329 CARDIAC RIGHT VENTRICLE MORPHOGENESIS 8 16 0.0001783 0.0006227
1330 REGULATION OF PLASMA MEMBRANE ORGANIZATION 20 73 0.0001777 0.0006227
1331 CELLULAR RESPONSE TO ANTIBIOTIC 8 16 0.0001783 0.0006227
1332 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 16 0.0001783 0.0006227
1333 POSITIVE REGULATION OF TELOMERE MAINTENANCE 15 47 0.0001805 0.0006296
1334 POSITIVE REGULATION OF GLIOGENESIS 15 47 0.0001805 0.0006296
1335 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 10 24 0.0001844 0.0006422
1336 NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 10 24 0.0001844 0.0006422
1337 NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS 90 535 0.000187 0.0006507
1338 CIRCADIAN RHYTHM 31 137 0.0001889 0.000657
1339 CALCIUM MEDIATED SIGNALING 23 90 0.0001898 0.0006597
1340 PROTEIN STABILIZATION 30 131 0.0001902 0.0006604
1341 STEROID HORMONE MEDIATED SIGNALING PATHWAY 29 125 0.0001903 0.0006605
1342 TONGUE DEVELOPMENT 9 20 0.0001921 0.0006637
1343 GENETIC IMPRINTING 9 20 0.0001921 0.0006637
1344 TRACHEA DEVELOPMENT 9 20 0.0001921 0.0006637
1345 NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 9 20 0.0001921 0.0006637
1346 REGULATION OF MACROPHAGE DIFFERENTIATION 9 20 0.0001921 0.0006637
1347 REGULATION OF MONOCYTE CHEMOTAXIS 9 20 0.0001921 0.0006637
1348 POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 19 68 0.0001932 0.0006669
1349 MAINTENANCE OF LOCATION IN CELL 24 96 0.0002002 0.0006904
1350 CHROMATIN REMODELING 33 150 0.0002095 0.000722
1351 CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 48 246 0.0002098 0.0007226
1352 RESPONSE TO INTERFERON GAMMA 32 144 0.0002137 0.0007353
1353 MUCOPOLYSACCHARIDE METABOLIC PROCESS 26 108 0.000214 0.000736
1354 DNA SYNTHESIS INVOLVED IN DNA REPAIR 20 74 0.0002173 0.0007466
1355 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 28 120 0.0002198 0.0007549
1356 SPINDLE LOCALIZATION 13 38 0.0002215 0.0007582
1357 RESPONSE TO TESTOSTERONE 13 38 0.0002215 0.0007582
1358 BONE MINERALIZATION 13 38 0.0002215 0.0007582
1359 CELLULAR RESPONSE TO DSRNA 13 38 0.0002215 0.0007582
1360 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 16 53 0.0002299 0.0007861
1361 CYTOSOLIC CALCIUM ION TRANSPORT 16 53 0.0002299 0.0007861
1362 PROTEIN TARGETING TO MEMBRANE 34 157 0.0002324 0.0007925
1363 MYELOID LEUKOCYTE MEDIATED IMMUNITY 14 43 0.0002325 0.0007925
1364 REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY 14 43 0.0002325 0.0007925
1365 REGULATION OF TELOMERASE ACTIVITY 14 43 0.0002325 0.0007925
1366 RESPONSE TO AMINE 15 48 0.0002346 0.0007992
1367 EPIDERMIS MORPHOGENESIS 11 29 0.0002385 0.0008093
1368 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 11 29 0.0002385 0.0008093
1369 T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 11 29 0.0002385 0.0008093
1370 EMBRYONIC HINDLIMB MORPHOGENESIS 11 29 0.0002385 0.0008093
1371 POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION 19 69 0.0002379 0.0008093
1372 DNA TEMPLATED TRANSCRIPTION INITIATION 41 202 0.0002498 0.000847
1373 POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 26 109 0.0002504 0.0008487
1374 NEGATIVE REGULATION OF ION TRANSPORT 29 127 0.0002542 0.0008609
1375 POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 7 13 0.0002572 0.0008639
1376 POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION 7 13 0.0002572 0.0008639
1377 ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME 7 13 0.0002572 0.0008639
1378 RELAXATION OF CARDIAC MUSCLE 7 13 0.0002572 0.0008639
1379 POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS 7 13 0.0002572 0.0008639
1380 LEUKOCYTE TETHERING OR ROLLING 7 13 0.0002572 0.0008639
1381 CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS 7 13 0.0002572 0.0008639
1382 RESPONSE TO HEPATOCYTE GROWTH FACTOR 7 13 0.0002572 0.0008639
1383 LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 7 13 0.0002572 0.0008639
1384 MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 7 13 0.0002572 0.0008639
1385 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 7 13 0.0002572 0.0008639
1386 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 42 209 0.0002645 0.000888
1387 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 10 25 0.0002755 0.0009181
1388 RESPONSE TO PROSTAGLANDIN E 10 25 0.0002755 0.0009181
1389 REGULATION OF PROTEIN DEACETYLATION 12 34 0.0002759 0.0009181
1390 CELLULAR EXTRAVASATION 10 25 0.0002755 0.0009181
1391 ADHERENS JUNCTION ASSEMBLY 12 34 0.0002759 0.0009181
1392 RESPONSE TO PROSTAGLANDIN 12 34 0.0002759 0.0009181
1393 CELLULAR RESPONSE TO TOXIC SUBSTANCE 10 25 0.0002755 0.0009181
1394 NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 10 25 0.0002755 0.0009181
1395 EPITHELIAL CELL APOPTOTIC PROCESS 10 25 0.0002755 0.0009181
1396 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 12 34 0.0002759 0.0009181
1397 NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION 12 34 0.0002759 0.0009181
1398 CAMP METABOLIC PROCESS 12 34 0.0002759 0.0009181
1399 REGULATION OF GENE EXPRESSION EPIGENETIC 45 229 0.0002762 0.0009186
1400 I KAPPAB KINASE NF KAPPAB SIGNALING 19 70 0.0002914 0.0009672
1401 MUSCLE ORGAN MORPHOGENESIS 19 70 0.0002914 0.0009672
1402 SPINDLE ASSEMBLY 19 70 0.0002914 0.0009672
1403 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 26 110 0.0002922 0.0009692
1404 REGULATION OF PHOSPHATASE ACTIVITY 29 128 0.0002928 0.0009696
1405 NEGATIVE REGULATION OF HEMOPOIESIS 29 128 0.0002928 0.0009696
1406 CELLULAR RESPONSE TO INTERFERON GAMMA 28 122 0.0002946 0.0009743
1407 CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT 27 116 0.0002945 0.0009743
1408 SULFUR COMPOUND CATABOLIC PROCESS 13 39 0.0002971 0.0009791
1409 TRABECULA MORPHOGENESIS 13 39 0.0002971 0.0009791
1410 ASTROCYTE DIFFERENTIATION 13 39 0.0002971 0.0009791
1411 COCHLEA DEVELOPMENT 13 39 0.0002971 0.0009791
1412 SPLEEN DEVELOPMENT 13 39 0.0002971 0.0009791
1413 METANEPHRIC NEPHRON MORPHOGENESIS 9 21 0.0003017 0.0009855
1414 NUCLEOSOME DISASSEMBLY 8 17 0.0003025 0.0009855
1415 DENDRITIC CELL MIGRATION 9 21 0.0003017 0.0009855
1416 PROTEIN DNA COMPLEX DISASSEMBLY 8 17 0.0003025 0.0009855
1417 DECIDUALIZATION 9 21 0.0003017 0.0009855
1418 REGULATION OF PLATELET AGGREGATION 8 17 0.0003025 0.0009855
1419 REGULATION OF GLIAL CELL PROLIFERATION 9 21 0.0003017 0.0009855
1420 CHROMATIN DISASSEMBLY 8 17 0.0003025 0.0009855
1421 CELL AGGREGATION 9 21 0.0003017 0.0009855
1422 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 15 49 0.0003022 0.0009855
1423 COCHLEA MORPHOGENESIS 9 21 0.0003017 0.0009855
1424 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 8 17 0.0003025 0.0009855
1425 BONE RESORPTION 9 21 0.0003017 0.0009855
1426 CARTILAGE CONDENSATION 9 21 0.0003017 0.0009855
1427 CARDIAC CELL DEVELOPMENT 15 49 0.0003022 0.0009855
1428 RESPONSE TO NITRIC OXIDE 9 21 0.0003017 0.0009855
1429 LABYRINTHINE LAYER DEVELOPMENT 14 44 0.0003049 0.0009913
1430 NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 14 44 0.0003049 0.0009913
1431 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 14 44 0.0003049 0.0009913
1432 MULTICELLULAR ORGANISM GROWTH 20 76 0.00032 0.00104
1433 DNA DEPENDENT DNA REPLICATION 24 99 0.0003293 0.001069
1434 ENDOMEMBRANE SYSTEM ORGANIZATION 79 465 0.0003293 0.001069
1435 PROTEIN ACETYLATION 29 129 0.0003364 0.00109
1436 RESPONSE TO ATP 11 30 0.0003372 0.00109
1437 CELLULAR RESPONSE TO ESTRADIOL STIMULUS 11 30 0.0003372 0.00109
1438 DOPAMINE RECEPTOR SIGNALING PATHWAY 11 30 0.0003372 0.00109
1439 LAMELLIPODIUM ASSEMBLY 11 30 0.0003372 0.00109
1440 TYROSINE PHOSPHORYLATION OF STAT PROTEIN 6 10 0.0003387 0.001094
1441 POSITIVE REGULATION OF CATABOLIC PROCESS 69 395 0.000344 0.001111
1442 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 17 60 0.0003446 0.001112
1443 REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 32 148 0.00036 0.001161
1444 NATURAL KILLER CELL ACTIVATION 16 55 0.0003677 0.001184
1445 REGULATION OF MYOTUBE DIFFERENTIATION 16 55 0.0003677 0.001184
1446 POSITIVE REGULATION OF VASOCONSTRICTION 12 35 0.0003757 0.001207
1447 REGULATION OF GASTRULATION 12 35 0.0003757 0.001207
1448 HAIR CELL DIFFERENTIATION 12 35 0.0003757 0.001207
1449 RESPONSE TO BMP 23 94 0.0003765 0.001208
1450 CELLULAR RESPONSE TO BMP STIMULUS 23 94 0.0003765 0.001208
1451 CELLULAR RESPONSE TO CAMP 15 50 0.0003858 0.001237
1452 SOMATIC STEM CELL POPULATION MAINTENANCE 18 66 0.0003911 0.001252
1453 FOREBRAIN GENERATION OF NEURONS 18 66 0.0003911 0.001252
1454 REGULATION OF VASOCONSTRICTION 18 66 0.0003911 0.001252
1455 REGULATION OF ACTIVATED T CELL PROLIFERATION 13 40 0.0003938 0.001258
1456 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 13 40 0.0003938 0.001258
1457 NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 10 26 0.0004013 0.001278
1458 REGULATION OF MESONEPHROS DEVELOPMENT 10 26 0.0004013 0.001278
1459 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 10 26 0.0004013 0.001278
1460 RESPONSE TO CORTICOSTERONE 10 26 0.0004013 0.001278
1461 STRAND DISPLACEMENT 10 26 0.0004013 0.001278
1462 PROTEOGLYCAN METABOLIC PROCESS 21 83 0.0004104 0.001306
1463 REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 37 181 0.0004223 0.001343
1464 OVARIAN FOLLICLE DEVELOPMENT 17 61 0.0004266 0.001355
1465 POSITIVE REGULATION OF CYCLASE ACTIVITY 17 61 0.0004266 0.001355
1466 RESPONSE TO HEAT 22 89 0.0004294 0.001362
1467 POSITIVE REGULATION OF CAMP METABOLIC PROCESS 22 89 0.0004294 0.001362
1468 CELL MATURATION 29 131 0.0004413 0.001398
1469 RETINA DEVELOPMENT IN CAMERA TYPE EYE 29 131 0.0004413 0.001398
1470 CANONICAL WNT SIGNALING PATHWAY 23 95 0.000443 0.001402
1471 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 26 113 0.0004569 0.001445
1472 NEGATIVE REGULATION OF MUSCLE CONTRACTION 9 22 0.0004581 0.001446
1473 POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION 9 22 0.0004581 0.001446
1474 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 9 22 0.0004581 0.001446
1475 SMAD PROTEIN SIGNAL TRANSDUCTION 16 56 0.0004599 0.001449
1476 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 7 14 0.0004627 0.001449
1477 REGULATION OF FIBROBLAST APOPTOTIC PROCESS 7 14 0.0004627 0.001449
1478 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 20 78 0.0004629 0.001449
1479 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 7 14 0.0004627 0.001449
1480 T CELL MIGRATION 7 14 0.0004627 0.001449
1481 DETERMINATION OF ADULT LIFESPAN 7 14 0.0004627 0.001449
1482 CRANIOFACIAL SUTURE MORPHOGENESIS 7 14 0.0004627 0.001449
1483 CELLULAR RESPONSE TO VITAMIN D 7 14 0.0004627 0.001449
1484 REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 7 14 0.0004627 0.001449
1485 RESPONSE TO LAMINAR FLUID SHEAR STRESS 7 14 0.0004627 0.001449
1486 PROGESTERONE METABOLIC PROCESS 7 14 0.0004627 0.001449
1487 REGULATION OF INTERLEUKIN 4 PRODUCTION 11 31 0.0004682 0.001458
1488 REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 11 31 0.0004682 0.001458
1489 NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 11 31 0.0004682 0.001458
1490 HYALURONAN METABOLIC PROCESS 11 31 0.0004682 0.001458
1491 REGULATION OF MAST CELL DEGRANULATION 11 31 0.0004682 0.001458
1492 MACROPHAGE ACTIVATION 11 31 0.0004682 0.001458
1493 HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE 11 31 0.0004682 0.001458
1494 MATERNAL PLACENTA DEVELOPMENT 11 31 0.0004682 0.001458
1495 MACROMOLECULE DEACYLATION 18 67 0.0004774 0.001483
1496 REGULATION OF TELOMERE MAINTENANCE 18 67 0.0004774 0.001483
1497 REGULATION OF NOTCH SIGNALING PATHWAY 18 67 0.0004774 0.001483
1498 CELLULAR RESPONSE TO DRUG 18 67 0.0004774 0.001483
1499 POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 15 51 0.0004885 0.001507
1500 NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 21 84 0.0004882 0.001507
1501 RETINAL GANGLION CELL AXON GUIDANCE 8 18 0.0004891 0.001507
1502 NEURAL CREST CELL MIGRATION 15 51 0.0004885 0.001507
1503 REGULATION OF HORMONE BIOSYNTHETIC PROCESS 8 18 0.0004891 0.001507
1504 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 15 51 0.0004885 0.001507
1505 MICROTUBULE ORGANIZING CENTER ORGANIZATION 21 84 0.0004882 0.001507
1506 PHARYNGEAL SYSTEM DEVELOPMENT 8 18 0.0004891 0.001507
1507 MAST CELL MEDIATED IMMUNITY 8 18 0.0004891 0.001507
1508 POSITIVE REGULATION OF PROTEIN DEACETYLATION 8 18 0.0004891 0.001507
1509 MUSCLE CELL MIGRATION 8 18 0.0004891 0.001507
1510 SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION 8 18 0.0004891 0.001507
1511 NEGATIVE REGULATION OF BLOOD CIRCULATION 12 36 0.0005045 0.001551
1512 POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 12 36 0.0005045 0.001551
1513 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 12 36 0.0005045 0.001551
1514 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 12 36 0.0005045 0.001551
1515 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 14 46 0.0005086 0.001562
1516 NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 13 41 0.0005159 0.001582
1517 AORTA DEVELOPMENT 13 41 0.0005159 0.001582
1518 HIPPOCAMPUS DEVELOPMENT 19 73 0.0005196 0.001589
1519 REGULATION OF ORGAN GROWTH 19 73 0.0005196 0.001589
1520 ICOSANOID METABOLIC PROCESS 23 96 0.0005195 0.001589
1521 FATTY ACID DERIVATIVE METABOLIC PROCESS 23 96 0.0005195 0.001589
1522 EMBRYONIC HEART TUBE MORPHOGENESIS 17 62 0.000525 0.001605
1523 NEGATIVE REGULATION OF PROTEIN SECRETION 25 108 0.0005292 0.001617
1524 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 10 27 0.0005714 0.001738
1525 POSITIVE REGULATION OF HEART GROWTH 10 27 0.0005714 0.001738
1526 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 10 27 0.0005714 0.001738
1527 MOTOR NEURON AXON GUIDANCE 10 27 0.0005714 0.001738
1528 NEGATIVE REGULATION OF AXON GUIDANCE 10 27 0.0005714 0.001738
1529 REGULATION OF HISTONE H3 K4 METHYLATION 10 27 0.0005714 0.001738
1530 APOPTOTIC MITOCHONDRIAL CHANGES 16 57 0.0005713 0.001738
1531 ORGANELLE ASSEMBLY 82 495 0.0005742 0.001745
1532 LIPID MODIFICATION 41 210 0.0005768 0.001752
1533 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 18 68 0.0005797 0.00176
1534 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 28 127 0.0005879 0.001783
1535 MITOTIC SISTER CHROMATID SEGREGATION 22 91 0.0005962 0.001807
1536 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 23 97 0.0006073 0.001839
1537 RESPONSE TO CALCIUM ION 26 115 0.0006076 0.001839
1538 ACTIVATION OF MAPKK ACTIVITY 15 52 0.0006136 0.001856
1539 REGULATION OF ACUTE INFLAMMATORY RESPONSE 19 74 0.000624 0.001885
1540 ACTIN MEDIATED CELL CONTRACTION 19 74 0.000624 0.001885
1541 REGULATION OF ORGAN FORMATION 11 32 0.0006392 0.001929
1542 EMBRYONIC FORELIMB MORPHOGENESIS 11 32 0.0006392 0.001929
1543 REGULATION OF CELL KILLING 17 63 0.0006422 0.001937
1544 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 14 47 0.0006478 0.001952
1545 CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 13 42 0.0006685 0.002004
1546 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 13 42 0.0006685 0.002004
1547 REGULATION OF MUSCLE HYPERTROPHY 12 37 0.0006685 0.002004
1548 REGULATION OF LAMELLIPODIUM ORGANIZATION 12 37 0.0006685 0.002004
1549 EPITHELIAL CELL MORPHOGENESIS 13 42 0.0006685 0.002004
1550 NEGATIVE REGULATION OF GTPASE ACTIVITY 13 42 0.0006685 0.002004
1551 REGULATION OF HEART GROWTH 13 42 0.0006685 0.002004
1552 CALCIUM ION IMPORT INTO CYTOSOL 13 42 0.0006685 0.002004
1553 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 6 11 0.0006718 0.002005
1554 REGULATION OF LIPID BIOSYNTHETIC PROCESS 28 128 0.0006706 0.002005
1555 POSITIVE REGULATION OF HAIR CYCLE 6 11 0.0006718 0.002005
1556 NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION 6 11 0.0006718 0.002005
1557 EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 6 11 0.0006718 0.002005
1558 CARDIAC CHAMBER FORMATION 6 11 0.0006718 0.002005
1559 PROSTATE GLANDULAR ACINUS DEVELOPMENT 6 11 0.0006718 0.002005
1560 PROSTATE GLAND MORPHOGENESIS 9 23 0.0006755 0.002007
1561 POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 9 23 0.0006755 0.002007
1562 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 9 23 0.0006755 0.002007
1563 REGULATION OF OSTEOBLAST PROLIFERATION 9 23 0.0006755 0.002007
1564 EPIBOLY 9 23 0.0006755 0.002007
1565 REGULATION OF ALPHA BETA T CELL PROLIFERATION 9 23 0.0006755 0.002007
1566 NEUROTROPHIN SIGNALING PATHWAY 9 23 0.0006755 0.002007
1567 REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 40 205 0.0006765 0.002009
1568 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 26 116 0.000698 0.002071
1569 UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 16 58 0.000705 0.002091
1570 NEURON MIGRATION 25 110 0.0007063 0.002093
1571 MEIOTIC CELL CYCLE 37 186 0.0007254 0.002148
1572 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 19 75 0.000746 0.002207
1573 BIOMINERAL TISSUE DEVELOPMENT 19 75 0.000746 0.002207
1574 FIBRIL ORGANIZATION 8 19 0.0007591 0.002234
1575 REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 8 19 0.0007591 0.002234
1576 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 19 0.0007591 0.002234
1577 CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 8 19 0.0007591 0.002234
1578 GLOMERULAR EPITHELIUM DEVELOPMENT 8 19 0.0007591 0.002234
1579 ATRIOVENTRICULAR VALVE DEVELOPMENT 8 19 0.0007591 0.002234
1580 CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES 8 19 0.0007591 0.002234
1581 ESTROUS CYCLE 8 19 0.0007591 0.002234
1582 REGULATION OF CAMP METABOLIC PROCESS 28 129 0.0007632 0.002245
1583 CELLULAR RESPONSE TO AMINO ACID STIMULUS 15 53 0.0007651 0.002249
1584 POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY 7 15 0.0007808 0.002272
1585 NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 17 64 0.0007812 0.002272
1586 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 7 15 0.0007808 0.002272
1587 RESPONSE TO MURAMYL DIPEPTIDE 7 15 0.0007808 0.002272
1588 NEGATIVE REGULATION OF HISTONE ACETYLATION 7 15 0.0007808 0.002272
1589 CELLULAR RESPONSE TO NITRIC OXIDE 7 15 0.0007808 0.002272
1590 ENDOCARDIAL CUSHION FORMATION 7 15 0.0007808 0.002272
1591 POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 7 15 0.0007808 0.002272
1592 POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 7 15 0.0007808 0.002272
1593 ECTODERMAL PLACODE DEVELOPMENT 7 15 0.0007808 0.002272
1594 JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY 7 15 0.0007808 0.002272
1595 NEGATIVE REGULATION OF B CELL PROLIFERATION 7 15 0.0007808 0.002272
1596 CHRONIC INFLAMMATORY RESPONSE 7 15 0.0007808 0.002272
1597 ECTODERMAL PLACODE MORPHOGENESIS 7 15 0.0007808 0.002272
1598 ECTODERMAL PLACODE FORMATION 7 15 0.0007808 0.002272
1599 T CELL APOPTOTIC PROCESS 7 15 0.0007808 0.002272
1600 RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 17 64 0.0007812 0.002272
1601 NEGATIVE REGULATION OF EXOCYTOSIS 10 28 0.000797 0.002306
1602 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 10 28 0.000797 0.002306
1603 POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 10 28 0.000797 0.002306
1604 MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS 10 28 0.000797 0.002306
1605 POSITIVE REGULATION OF TELOMERASE ACTIVITY 10 28 0.000797 0.002306
1606 AUDITORY RECEPTOR CELL DIFFERENTIATION 10 28 0.000797 0.002306
1607 MORPHOGENESIS OF A POLARIZED EPITHELIUM 10 28 0.000797 0.002306
1608 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 10 28 0.000797 0.002306
1609 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 26 117 8e-04 0.002313
1610 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 14 48 0.000818 0.002361
1611 REGULATION OF MYOBLAST DIFFERENTIATION 14 48 0.000818 0.002361
1612 POSITIVE REGULATION OF WOUND HEALING 14 48 0.000818 0.002361
1613 CEREBRAL CORTEX DEVELOPMENT 24 105 0.0008204 0.002367
1614 MACROMOLECULE CATABOLIC PROCESS 139 926 0.0008397 0.002421
1615 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 13 43 0.0008574 0.002466
1616 SUPEROXIDE METABOLIC PROCESS 11 33 0.0008591 0.002466
1617 REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 13 43 0.0008574 0.002466
1618 SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 11 33 0.0008591 0.002466
1619 CELL FATE DETERMINATION 13 43 0.0008574 0.002466
1620 EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 11 33 0.0008591 0.002466
1621 G2 DNA DAMAGE CHECKPOINT 11 33 0.0008591 0.002466
1622 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 16 59 0.0008644 0.00248
1623 REGULATION OF DOUBLE STRAND BREAK REPAIR 12 38 0.0008748 0.002507
1624 POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 12 38 0.0008748 0.002507
1625 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 30 143 0.0009121 0.002612
1626 REGULATION OF CHEMOKINE PRODUCTION 17 65 0.000945 0.002703
1627 REGULATION OF RESPONSE TO OXIDATIVE STRESS 17 65 0.000945 0.002703
1628 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 53 297 0.0009615 0.002748
1629 FOCAL ADHESION ASSEMBLY 9 24 0.0009701 0.002759
1630 REGULATION OF MYELOID CELL APOPTOTIC PROCESS 9 24 0.0009701 0.002759
1631 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 9 24 0.0009701 0.002759
1632 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 9 24 0.0009701 0.002759
1633 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 9 24 0.0009701 0.002759
1634 CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY 9 24 0.0009701 0.002759
1635 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 9 24 0.0009701 0.002759
1636 REGULATION OF T CELL MIGRATION 9 24 0.0009701 0.002759
1637 BODY FLUID SECRETION 18 71 0.001007 0.002863
1638 ACTIN FILAMENT BUNDLE ORGANIZATION 14 49 0.001024 0.002906
1639 HEXOSE CATABOLIC PROCESS 14 49 0.001024 0.002906
1640 LYMPHOCYTE MIGRATION 14 49 0.001024 0.002906
1641 REGULATION OF SYNAPSE ORGANIZATION 25 113 0.001068 0.003028
1642 NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY 13 44 0.001089 0.003086
1643 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 10 29 0.001091 0.003089
1644 FOREBRAIN NEURON DEVELOPMENT 11 34 0.001138 0.003192
1645 LUNG EPITHELIUM DEVELOPMENT 11 34 0.001138 0.003192
1646 ATP GENERATION FROM ADP 12 39 0.001132 0.003192
1647 POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 12 39 0.001132 0.003192
1648 NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY 11 34 0.001138 0.003192
1649 CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 11 34 0.001138 0.003192
1650 ER NUCLEUS SIGNALING PATHWAY 11 34 0.001138 0.003192
1651 REGULATION OF MAST CELL ACTIVATION 12 39 0.001132 0.003192
1652 RENAL WATER HOMEOSTASIS 11 34 0.001138 0.003192
1653 REGULATION OF CENTROSOME CYCLE 12 39 0.001132 0.003192
1654 PARTURITION 8 20 0.001137 0.003192
1655 ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS 8 20 0.001137 0.003192
1656 REGULATION OF CARDIAC CONDUCTION 17 66 0.001137 0.003192
1657 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 8 20 0.001137 0.003192
1658 RESPONSE TO LEAD ION 8 20 0.001137 0.003192
1659 LENS DEVELOPMENT IN CAMERA TYPE EYE 17 66 0.001137 0.003192
1660 GAMETE GENERATION 94 595 0.001174 0.00329
1661 SMOOTHENED SIGNALING PATHWAY 18 72 0.001199 0.00336
1662 NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 29 139 0.001204 0.003364
1663 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 6 12 0.001212 0.003364
1664 REGULATION OF SUPEROXIDE ANION GENERATION 6 12 0.001212 0.003364
1665 REGULATION OF VITAMIN METABOLIC PROCESS 6 12 0.001212 0.003364
1666 AXON EXTENSION INVOLVED IN AXON GUIDANCE 6 12 0.001212 0.003364
1667 REGULATION OF GLOMERULAR FILTRATION 6 12 0.001212 0.003364
1668 REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 6 12 0.001212 0.003364
1669 CELLULAR RESPONSE TO ATP 6 12 0.001212 0.003364
1670 HEMIDESMOSOME ASSEMBLY 6 12 0.001212 0.003364
1671 ANATOMICAL STRUCTURE REGRESSION 6 12 0.001212 0.003364
1672 CELLULAR RESPONSE TO EPINEPHRINE STIMULUS 6 12 0.001212 0.003364
1673 KERATAN SULFATE CATABOLIC PROCESS 6 12 0.001212 0.003364
1674 REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER 6 12 0.001212 0.003364
1675 REPLICATIVE SENESCENCE 6 12 0.001212 0.003364
1676 POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION 6 12 0.001212 0.003364
1677 SEXUAL REPRODUCTION 112 730 0.001221 0.003388
1678 ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY 7 16 0.001249 0.003444
1679 REGULATION OF GRANULOCYTE DIFFERENTIATION 7 16 0.001249 0.003444
1680 REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING 7 16 0.001249 0.003444
1681 NEGATIVE REGULATION OF HISTONE METHYLATION 7 16 0.001249 0.003444
1682 NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS 7 16 0.001249 0.003444
1683 CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 46 252 0.001247 0.003444
1684 REGULATION OF INTERLEUKIN 6 BIOSYNTHETIC PROCESS 7 16 0.001249 0.003444
1685 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT1 PROTEIN 7 16 0.001249 0.003444
1686 FEMALE GENITALIA DEVELOPMENT 7 16 0.001249 0.003444
1687 ATRIOVENTRICULAR VALVE MORPHOGENESIS 7 16 0.001249 0.003444
1688 REGULATION OF DEVELOPMENTAL PIGMENTATION 7 16 0.001249 0.003444
1689 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 28 133 0.001255 0.003455
1690 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 28 133 0.001255 0.003455
1691 HISTONE METHYLATION 20 84 0.001268 0.003488
1692 NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION 20 84 0.001268 0.003488
1693 VISUAL BEHAVIOR 14 50 0.001273 0.003498
1694 NUCLEOTIDE PHOSPHORYLATION 16 61 0.001276 0.003504
1695 CHROMOSOME LOCALIZATION 16 61 0.001276 0.003504
1696 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 9 25 0.001361 0.003729
1697 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 25 0.001361 0.003729
1698 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 9 25 0.001361 0.003729
1699 ENDOTHELIAL CELL DEVELOPMENT 13 45 0.001371 0.00375
1700 POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 13 45 0.001371 0.00375
1701 MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY 13 45 0.001371 0.00375
1702 PANCREAS DEVELOPMENT 18 73 0.001422 0.003885
1703 EMBRYONIC HEART TUBE DEVELOPMENT 18 73 0.001422 0.003885
1704 FORELIMB MORPHOGENESIS 12 40 0.001448 0.003944
1705 LYMPHOCYTE MEDIATED IMMUNITY 30 147 0.001448 0.003944
1706 ENDOCRINE PANCREAS DEVELOPMENT 12 40 0.001448 0.003944
1707 ENDODERMAL CELL DIFFERENTIATION 12 40 0.001448 0.003944
1708 REGULATION OF FILOPODIUM ASSEMBLY 12 40 0.001448 0.003944
1709 REGULATION OF SYNAPSE ASSEMBLY 19 79 0.001461 0.003977
1710 LEUKOCYTE DEGRANULATION 10 30 0.001468 0.003984
1711 NEGATIVE REGULATION OF B CELL ACTIVATION 10 30 0.001468 0.003984
1712 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 10 30 0.001468 0.003984
1713 RESPONSE TO AMPHETAMINE 10 30 0.001468 0.003984
1714 REGULATION OF VASCULAR PERMEABILITY 10 30 0.001468 0.003984
1715 CELLULAR RESPONSE TO LIGHT STIMULUS 21 91 0.001485 0.004026
1716 POSITIVE REGULATION OF HEART CONTRACTION 11 35 0.001487 0.004026
1717 MEMBRANE PROTEIN PROTEOLYSIS 11 35 0.001487 0.004026
1718 CLATHRIN MEDIATED ENDOCYTOSIS 11 35 0.001487 0.004026
1719 RESPONSE TO IRON ION 11 35 0.001487 0.004026
1720 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 24 110 0.001627 0.004401
1721 REGULATION OF CHROMATIN SILENCING 8 21 0.001651 0.004452
1722 T HELPER 1 TYPE IMMUNE RESPONSE 8 21 0.001651 0.004452
1723 NEGATIVE REGULATION OF PROTEIN ACETYLATION 8 21 0.001651 0.004452
1724 CELLULAR RESPONSE TO OSMOTIC STRESS 8 21 0.001651 0.004452
1725 RUFFLE ORGANIZATION 8 21 0.001651 0.004452
1726 SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS 8 21 0.001651 0.004452
1727 REGULATION OF STEROID METABOLIC PROCESS 18 74 0.001679 0.004522
1728 PROTEIN IMPORT 31 155 0.001711 0.004597
1729 NEGATIVE REGULATION OF CYTOKINE SECRETION 13 46 0.001711 0.004597
1730 REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH 13 46 0.001711 0.004597
1731 RECOMBINATIONAL REPAIR 19 80 0.001711 0.004597
1732 HISTONE H3 ACETYLATION 13 46 0.001711 0.004597
1733 PIGMENTATION 20 86 0.001722 0.004625
1734 CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 93 595 0.001734 0.004654
1735 CELLULAR RESPONSE TO ESTROGEN STIMULUS 12 41 0.001833 0.004911
1736 MONOCYTE CHEMOTAXIS 12 41 0.001833 0.004911
1737 ANDROGEN RECEPTOR SIGNALING PATHWAY 12 41 0.001833 0.004911
1738 REGULATION OF OSTEOCLAST DIFFERENTIATION 16 63 0.001842 0.004933
1739 SISTER CHROMATID COHESION 24 111 0.001851 0.004954
1740 CELLULAR RESPONSE TO INTERLEUKIN 4 9 26 0.001869 0.004989
1741 CELLULAR RESPONSE TO VITAMIN 9 26 0.001869 0.004989
1742 INACTIVATION OF MAPK ACTIVITY 9 26 0.001869 0.004989
1743 REGULATION OF CELL FATE COMMITMENT 9 26 0.001869 0.004989
1744 REGULATION OF BLOOD PRESSURE 33 169 0.001877 0.005009
1745 NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 7 17 0.001912 0.005056
1746 BRANCH ELONGATION OF AN EPITHELIUM 7 17 0.001912 0.005056
1747 NEGATIVE REGULATION OF PLATELET ACTIVATION 7 17 0.001912 0.005056
1748 RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME 7 17 0.001912 0.005056
1749 LYMPH NODE DEVELOPMENT 7 17 0.001912 0.005056
1750 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 7 17 0.001912 0.005056
1751 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 7 17 0.001912 0.005056
1752 NEGATIVE REGULATION OF TISSUE REMODELING 7 17 0.001912 0.005056
1753 POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 7 17 0.001912 0.005056
1754 ESTABLISHMENT OF TISSUE POLARITY 7 17 0.001912 0.005056
1755 REGULATION OF HISTONE H3 K9 METHYLATION 7 17 0.001912 0.005056
1756 INTESTINAL EPITHELIAL CELL DIFFERENTIATION 7 17 0.001912 0.005056
1757 POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 17 0.001912 0.005056
1758 REGULATION OF SISTER CHROMATID COHESION 7 17 0.001912 0.005056
1759 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 7 17 0.001912 0.005056
1760 FILOPODIUM ASSEMBLY 7 17 0.001912 0.005056
1761 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 11 36 0.00192 0.005068
1762 NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 14 52 0.001921 0.005068
1763 POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 17 69 0.001923 0.005068
1764 CELLULAR RESPONSE TO HEAT 11 36 0.00192 0.005068
1765 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 17 69 0.001923 0.005068
1766 RESPONSE TO ACTIVITY 17 69 0.001923 0.005068
1767 RESPONSE TO INTERLEUKIN 4 10 31 0.001944 0.005113
1768 CARDIAC ATRIUM DEVELOPMENT 10 31 0.001944 0.005113
1769 REGULATION OF MICROTUBULE POLYMERIZATION 10 31 0.001944 0.005113
1770 SENSORY PERCEPTION OF PAIN 18 75 0.001973 0.005187
1771 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 20 87 0.001997 0.005247
1772 NEURONAL STEM CELL DIVISION 6 13 0.00203 0.005291
1773 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 6 13 0.00203 0.005291
1774 POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 6 13 0.00203 0.005291
1775 PROTEIN LOCALIZATION TO CHROMATIN 6 13 0.00203 0.005291
1776 CARDIOBLAST DIFFERENTIATION 6 13 0.00203 0.005291
1777 NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 6 13 0.00203 0.005291
1778 POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 6 13 0.00203 0.005291
1779 NEGATIVE T CELL SELECTION 6 13 0.00203 0.005291
1780 SUPEROXIDE ANION GENERATION 6 13 0.00203 0.005291
1781 NEUROBLAST DIVISION 6 13 0.00203 0.005291
1782 MESENCHYMAL CELL PROLIFERATION 6 13 0.00203 0.005291
1783 REGULATION OF CELL FATE SPECIFICATION 6 13 0.00203 0.005291
1784 EXTRACELLULAR FIBRIL ORGANIZATION 6 13 0.00203 0.005291
1785 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 6 13 0.00203 0.005291
1786 NEGATIVE REGULATION OF WOUND HEALING 15 58 0.002082 0.005421
1787 PROTEOGLYCAN BIOSYNTHETIC PROCESS 15 58 0.002082 0.005421
1788 MULTI ORGANISM METABOLIC PROCESS 28 138 0.002236 0.005819
1789 POSITIVE REGULATION OF HORMONE SECRETION 25 119 0.002289 0.005955
1790 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 12 42 0.002299 0.005974
1791 METAPHASE PLATE CONGRESSION 12 42 0.002299 0.005974
1792 GLIAL CELL DEVELOPMENT 18 76 0.00231 0.005997
1793 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 8 22 0.002333 0.006031
1794 NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY 8 22 0.002333 0.006031
1795 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 22 0.002333 0.006031
1796 POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 8 22 0.002333 0.006031
1797 DSRNA FRAGMENTATION 8 22 0.002333 0.006031
1798 AORTA MORPHOGENESIS 8 22 0.002333 0.006031
1799 HISTONE H3 DEACETYLATION 8 22 0.002333 0.006031
1800 PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA 8 22 0.002333 0.006031
1801 REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY 14 53 0.002337 0.006033
1802 REGULATION OF TRANSPORTER ACTIVITY 37 198 0.002336 0.006033
1803 CARBOHYDRATE CATABOLIC PROCESS 24 113 0.002381 0.006144
1804 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 11 37 0.002449 0.00629
1805 POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 11 37 0.002449 0.00629
1806 MYOBLAST DIFFERENTIATION 11 37 0.002449 0.00629
1807 MODULATION BY VIRUS OF HOST MORPHOLOGY OR PHYSIOLOGY 11 37 0.002449 0.00629
1808 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 11 37 0.002449 0.00629
1809 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 11 37 0.002449 0.00629
1810 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 11 37 0.002449 0.00629
1811 AXON EXTENSION 11 37 0.002449 0.00629
1812 CAMP MEDIATED SIGNALING 11 37 0.002449 0.00629
1813 MEIOTIC CELL CYCLE PROCESS 30 152 0.002484 0.006375
1814 MONOSACCHARIDE CATABOLIC PROCESS 15 59 0.002497 0.006401
1815 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 15 59 0.002497 0.006401
1816 POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 36 192 0.0025 0.006406
1817 REGULATION OF ACTIN NUCLEATION 9 27 0.002518 0.006416
1818 ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 9 27 0.002518 0.006416
1819 REGULATION OF LAMELLIPODIUM ASSEMBLY 9 27 0.002518 0.006416
1820 NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION 9 27 0.002518 0.006416
1821 REGULATION OF ASTROCYTE DIFFERENTIATION 9 27 0.002518 0.006416
1822 NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 9 27 0.002518 0.006416
1823 REGULATION OF CATENIN IMPORT INTO NUCLEUS 9 27 0.002518 0.006416
1824 REGULATION OF KERATINOCYTE DIFFERENTIATION 9 27 0.002518 0.006416
1825 SUBSTRATE DEPENDENT CELL MIGRATION 9 27 0.002518 0.006416
1826 HETEROTYPIC CELL CELL ADHESION 9 27 0.002518 0.006416
1827 TELOMERE MAINTENANCE VIA RECOMBINATION 10 32 0.002537 0.006453
1828 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 10 32 0.002537 0.006453
1829 POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 10 32 0.002537 0.006453
1830 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 22 101 0.002543 0.006465
1831 POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 13 48 0.002599 0.006602
1832 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 13 48 0.002599 0.006602
1833 PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 16 65 0.002605 0.006612
1834 ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS 18 77 0.002693 0.006833
1835 REGULATION OF COLLATERAL SPROUTING 7 18 0.002818 0.007114
1836 CELLULAR COMPONENT MAINTENANCE 7 18 0.002818 0.007114
1837 REGULATION OF TOLERANCE INDUCTION 7 18 0.002818 0.007114
1838 ORGAN MATURATION 7 18 0.002818 0.007114
1839 POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY 7 18 0.002818 0.007114
1840 CELL DEATH IN RESPONSE TO OXIDATIVE STRESS 7 18 0.002818 0.007114
1841 OVULATION 7 18 0.002818 0.007114
1842 PERICARDIUM DEVELOPMENT 7 18 0.002818 0.007114
1843 OSTEOBLAST DEVELOPMENT 7 18 0.002818 0.007114
1844 CARBOHYDRATE BIOSYNTHETIC PROCESS 25 121 0.0029 0.007318
1845 T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 15 60 0.002978 0.007507
1846 CELLULAR DEFENSE RESPONSE 15 60 0.002978 0.007507
1847 ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 72 450 0.003011 0.007586
1848 MIDBRAIN DEVELOPMENT 20 90 0.003051 0.007683
1849 REGULATION OF MULTICELLULAR ORGANISM GROWTH 16 66 0.003074 0.007737
1850 NEGATIVE REGULATION OF AXON EXTENSION 11 38 0.003091 0.00777
1851 CYTOKINE SECRETION 11 38 0.003091 0.00777
1852 UNSATURATED FATTY ACID METABOLIC PROCESS 23 109 0.003162 0.007944
1853 STRESS FIBER ASSEMBLY 6 14 0.003205 0.008013
1854 OUTFLOW TRACT SEPTUM MORPHOGENESIS 6 14 0.003205 0.008013
1855 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 6 14 0.003205 0.008013
1856 CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY 6 14 0.003205 0.008013
1857 RENAL VESICLE DEVELOPMENT 6 14 0.003205 0.008013
1858 NEGATIVE REGULATION OF JUN KINASE ACTIVITY 6 14 0.003205 0.008013
1859 POSITIVE REGULATION OF HISTONE DEACETYLATION 6 14 0.003205 0.008013
1860 POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 6 14 0.003205 0.008013
1861 PEPTIDYL ARGININE METHYLATION 6 14 0.003205 0.008013
1862 REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY 8 23 0.003217 0.008013
1863 SYNAPTIC VESICLE RECYCLING 8 23 0.003217 0.008013
1864 LYSOSOME LOCALIZATION 8 23 0.003217 0.008013
1865 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE I PROMOTER 8 23 0.003217 0.008013
1866 PROTEIN TARGETING TO PLASMA MEMBRANE 8 23 0.003217 0.008013
1867 REGULATION OF SUPEROXIDE METABOLIC PROCESS 8 23 0.003217 0.008013
1868 TRABECULA FORMATION 8 23 0.003217 0.008013
1869 CELLULAR SENESCENCE 10 33 0.003266 0.008131
1870 PHOSPHOLIPID METABOLIC PROCESS 60 364 0.00328 0.008161
1871 MONOSACCHARIDE METABOLIC PROCESS 37 202 0.003323 0.008264
1872 NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY 9 28 0.003333 0.008271
1873 PLACENTA BLOOD VESSEL DEVELOPMENT 9 28 0.003333 0.008271
1874 NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 9 28 0.003333 0.008271
1875 REGULATION OF NEUROBLAST PROLIFERATION 9 28 0.003333 0.008271
1876 ORGANONITROGEN COMPOUND CATABOLIC PROCESS 57 343 0.003414 0.008468
1877 ENSHEATHMENT OF NEURONS 20 91 0.003493 0.008653
1878 AXON ENSHEATHMENT 20 91 0.003493 0.008653
1879 NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 12 44 0.003521 0.008719
1880 POSITIVE REGULATION OF LYASE ACTIVITY 15 61 0.003533 0.008744
1881 PROTEIN POLYMERIZATION 16 67 0.003612 0.008935
1882 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 13 50 0.003834 0.009444
1883 REGULATION OF RECEPTOR ACTIVITY 24 117 0.00383 0.009444
1884 PROTEIN METHYLATION 24 117 0.00383 0.009444
1885 CELLULAR RESPONSE TO STARVATION 24 117 0.00383 0.009444
1886 PURINE CONTAINING COMPOUND CATABOLIC PROCESS 13 50 0.003834 0.009444
1887 PROTEIN ALKYLATION 24 117 0.00383 0.009444
1888 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 13 50 0.003834 0.009444
1889 RHO PROTEIN SIGNAL TRANSDUCTION 13 50 0.003834 0.009444
1890 MEMORY 21 98 0.003859 0.009479
1891 REGULATION OF LIGASE ACTIVITY 26 130 0.003854 0.009479
1892 ERBB2 SIGNALING PATHWAY 11 39 0.00386 0.009479
1893 POSITIVE REGULATION OF CELL KILLING 11 39 0.00386 0.009479
1894 NEGATIVE CHEMOTAXIS 11 39 0.00386 0.009479
1895 CYTOSKELETON DEPENDENT CYTOKINESIS 11 39 0.00386 0.009479
1896 POSITIVE REGULATION OF VIRAL PROCESS 20 92 0.003986 0.009782
1897 DENDRITIC SPINE DEVELOPMENT 7 19 0.004019 0.009837
1898 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 7 19 0.004019 0.009837
1899 NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 7 19 0.004019 0.009837
1900 REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 7 19 0.004019 0.009837
1901 NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING 7 19 0.004019 0.009837
NumGOOverlapSizeP ValueAdj. P Value
1 MACROMOLECULAR COMPLEX BINDING 361 1399 6.021e-53 5.594e-50
2 KINASE ACTIVITY 249 842 3.446e-47 1.601e-44
3 ENZYME BINDING 398 1737 1.49e-44 4.613e-42
4 RIBONUCLEOTIDE BINDING 417 1860 2.676e-44 6.216e-42
5 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 305 1199 5.082e-43 9.443e-41
6 PROTEIN KINASE ACTIVITY 201 640 2.69e-42 4.165e-40
7 ADENYL NUCLEOTIDE BINDING 350 1514 9.603e-40 1.275e-37
8 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 261 992 2.136e-39 2.48e-37
9 REGULATORY REGION NUCLEIC ACID BINDING 226 818 1.335e-37 1.378e-35
10 PROTEIN COMPLEX BINDING 245 935 1.241e-36 1.152e-34
11 SEQUENCE SPECIFIC DNA BINDING 262 1037 2.907e-36 2.455e-34
12 RECEPTOR BINDING 330 1476 2.551e-34 1.975e-32
13 DOUBLE STRANDED DNA BINDING 208 764 1.303e-33 9.312e-32
14 KINASE BINDING 168 606 3.235e-28 2.147e-26
15 PROTEIN SERINE THREONINE KINASE ACTIVITY 132 445 2.463e-25 1.525e-23
16 MOLECULAR FUNCTION REGULATOR 280 1353 1.965e-23 1.081e-21
17 PROTEIN DOMAIN SPECIFIC BINDING 161 624 1.979e-23 1.081e-21
18 CHROMATIN BINDING 126 435 3.249e-23 1.677e-21
19 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 161 629 4.858e-23 2.375e-21
20 CORE PROMOTER PROXIMAL REGION DNA BINDING 112 371 2.432e-22 1.13e-20
21 IDENTICAL PROTEIN BINDING 254 1209 3.33e-22 1.473e-20
22 PROTEIN DIMERIZATION ACTIVITY 244 1149 5.426e-22 2.291e-20
23 TRANSCRIPTION FACTOR BINDING 139 524 1.519e-21 6.136e-20
24 PROTEIN TYROSINE KINASE ACTIVITY 69 176 3.809e-21 1.474e-19
25 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 148 588 1.646e-20 6.118e-19
26 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 100 328 2.025e-20 7.236e-19
27 RECEPTOR SIGNALING PROTEIN ACTIVITY 64 172 2.425e-18 8.343e-17
28 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 41 81 6.436e-18 2.135e-16
29 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 36 64 7.158e-18 2.293e-16
30 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 92 315 1.551e-17 4.804e-16
31 CORE PROMOTER BINDING 58 152 2.394e-17 7.175e-16
32 CYTOSKELETAL PROTEIN BINDING 178 819 2.931e-17 8.509e-16
33 ENZYME REGULATOR ACTIVITY 200 959 3.114e-17 8.766e-16
34 PROTEIN HOMODIMERIZATION ACTIVITY 160 722 2.058e-16 5.622e-15
35 CELL ADHESION MOLECULE BINDING 64 186 2.223e-16 5.901e-15
36 INTEGRIN BINDING 45 105 5.25e-16 1.355e-14
37 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 70 226 4.38e-15 1.1e-13
38 PROTEIN C TERMINUS BINDING 60 186 5.281e-14 1.291e-12
39 GROWTH FACTOR BINDING 46 123 1.121e-13 2.671e-12
40 SH3 DOMAIN BINDING 44 116 2.137e-13 4.962e-12
41 TRANSCRIPTION COACTIVATOR ACTIVITY 79 296 6.075e-13 1.377e-11
42 HISTONE DEACETYLASE BINDING 40 105 2.224e-12 4.919e-11
43 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 36 92 1.108e-11 2.393e-10
44 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 38 101 1.223e-11 2.582e-10
45 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 76 303 4.467e-11 9.222e-10
46 ENHANCER BINDING 35 93 7.761e-11 1.567e-09
47 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 62 228 7.975e-11 1.576e-09
48 KINASE REGULATOR ACTIVITY 54 186 9.211e-11 1.783e-09
49 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 37 104 1.51e-10 2.862e-09
50 ENZYME ACTIVATOR ACTIVITY 102 471 2.614e-10 4.856e-09
51 PROTEIN HETERODIMERIZATION ACTIVITY 101 468 3.916e-10 7.133e-09
52 STEROID HORMONE RECEPTOR BINDING 31 81 5.683e-10 1.015e-08
53 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 77 329 1.088e-09 1.908e-08
54 NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY 22 46 1.2e-09 2.065e-08
55 GLYCOPROTEIN BINDING 34 101 4.339e-09 7.33e-08
56 ACTIN BINDING 85 393 8.602e-09 1.427e-07
57 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 28 76 1.036e-08 1.688e-07
58 GLYCOSAMINOGLYCAN BINDING 53 205 1.243e-08 1.991e-07
59 EXTRACELLULAR MATRIX BINDING 22 51 1.329e-08 2.092e-07
60 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 28 77 1.448e-08 2.242e-07
61 UBIQUITIN LIKE PROTEIN LIGASE BINDING 63 264 1.597e-08 2.432e-07
62 ACTIVATING TRANSCRIPTION FACTOR BINDING 23 57 2.895e-08 4.337e-07
63 PHOSPHATASE BINDING 44 162 4.435e-08 6.54e-07
64 LIPID BINDING 123 657 4.615e-08 6.596e-07
65 CYTOKINE RECEPTOR BINDING 63 271 4.551e-08 6.596e-07
66 PROTEIN PHOSPHATASE BINDING 36 120 4.743e-08 6.677e-07
67 HORMONE RECEPTOR BINDING 45 168 4.924e-08 6.827e-07
68 SIGNAL TRANSDUCER ACTIVITY 272 1731 5.501e-08 7.515e-07
69 ION CHANNEL BINDING 34 111 6.305e-08 8.489e-07
70 HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES 146 820 6.984e-08 9.269e-07
71 COLLAGEN BINDING 24 65 1.098e-07 1.437e-06
72 GUANYL NUCLEOTIDE BINDING 81 390 1.219e-07 1.572e-06
73 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 25 70 1.279e-07 1.628e-06
74 HEAT SHOCK PROTEIN BINDING 29 89 1.31e-07 1.645e-06
75 HISTONE KINASE ACTIVITY 12 19 1.353e-07 1.676e-06
76 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 44 168 1.397e-07 1.708e-06
77 RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 21 53 1.672e-07 2.003e-06
78 PLATELET DERIVED GROWTH FACTOR BINDING 9 11 1.682e-07 2.003e-06
79 PHOSPHORIC ESTER HYDROLASE ACTIVITY 77 368 1.809e-07 2.128e-06
80 STRUCTURE SPECIFIC DNA BINDING 34 118 3.23e-07 3.751e-06
81 PROTEIN N TERMINUS BINDING 31 103 3.667e-07 4.205e-06
82 PHOSPHOPROTEIN BINDING 22 60 4.248e-07 4.812e-06
83 G PROTEIN COUPLED RECEPTOR BINDING 58 259 5.824e-07 6.518e-06
84 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 28 90 6.283e-07 6.949e-06
85 PHOSPHATIDYLINOSITOL PHOSPHATE BINDING 33 116 6.604e-07 7.134e-06
86 PHOSPHATIDYLINOSITOL BINDING 48 200 6.585e-07 7.134e-06
87 PHOSPHATASE ACTIVITY 60 275 9.467e-07 1.011e-05
88 CYTOKINE BINDING 28 92 1.033e-06 1.091e-05
89 HEPARIN BINDING 40 157 1.097e-06 1.145e-05
90 PROTEIN TYROSINE PHOSPHATASE ACTIVITY 30 103 1.217e-06 1.257e-05
91 PHOSPHOLIPID BINDING 73 360 1.298e-06 1.325e-05
92 MOTOR ACTIVITY 35 131 1.555e-06 1.571e-05
93 KINASE INHIBITOR ACTIVITY 27 89 1.717e-06 1.715e-05
94 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 30 105 1.897e-06 1.875e-05
95 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 43 178 2.051e-06 1.984e-05
96 RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC DNA BINDING 22 65 2.045e-06 1.984e-05
97 VIRUS RECEPTOR ACTIVITY 23 70 2.165e-06 2.073e-05
98 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 35 133 2.273e-06 2.155e-05
99 ANDROGEN RECEPTOR BINDING 16 39 2.858e-06 2.682e-05
100 WNT PROTEIN BINDING 14 31 3.037e-06 2.821e-05
101 SEMAPHORIN RECEPTOR ACTIVITY 8 11 3.919e-06 3.604e-05
102 MITOGEN ACTIVATED PROTEIN KINASE BINDING 12 24 4.145e-06 3.739e-05
103 EPHRIN RECEPTOR BINDING 12 24 4.145e-06 3.739e-05
104 MAP KINASE ACTIVITY 9 14 4.405e-06 3.935e-05
105 BHLH TRANSCRIPTION FACTOR BINDING 13 28 4.694e-06 4.114e-05
106 FIBRONECTIN BINDING 13 28 4.694e-06 4.114e-05
107 TRANSCRIPTION COREPRESSOR ACTIVITY 49 221 5.68e-06 4.932e-05
108 BINDING BRIDGING 41 173 5.834e-06 5.019e-05
109 SULFUR COMPOUND BINDING 51 234 6.197e-06 5.281e-05
110 PROTEIN KINASE C BINDING 18 50 6.379e-06 5.388e-05
111 TUBULIN BINDING 57 273 7.306e-06 6.115e-05
112 CHROMATIN DNA BINDING 24 80 7.878e-06 6.534e-05
113 SMAD BINDING 22 72 1.345e-05 0.0001106
114 ACTIN FILAMENT BINDING 31 121 1.512e-05 0.0001221
115 EPHRIN RECEPTOR ACTIVITY 10 19 1.504e-05 0.0001221
116 DAMAGED DNA BINDING 20 63 1.752e-05 0.0001403
117 BETA CATENIN BINDING 24 84 1.963e-05 0.0001559
118 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY 9 16 2.023e-05 0.0001593
119 S100 PROTEIN BINDING 8 13 2.462e-05 0.0001922
120 PROTEIN PHOSPHORYLATED AMINO ACID BINDING 11 24 2.99e-05 0.0002315
121 MAGNESIUM ION BINDING 43 199 3.968e-05 0.0003047
122 CORECEPTOR ACTIVITY 14 38 5.028e-05 0.0003829
123 C2H2 ZINC FINGER DOMAIN BINDING 8 14 5.158e-05 0.0003896
124 GROWTH FACTOR RECEPTOR BINDING 31 129 5.772e-05 0.0004325
125 PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING 13 34 5.934e-05 0.000441
126 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 12 30 6.786e-05 0.0004964
127 LAMININ BINDING 12 30 6.786e-05 0.0004964
128 GTPASE BINDING 57 295 7.502e-05 0.0005445
129 WNT ACTIVATED RECEPTOR ACTIVITY 10 22 7.571e-05 0.0005452
130 CHAPERONE BINDING 22 81 9.919e-05 0.0007088
131 RNA BINDING 233 1598 0.0001063 0.0007541
132 MICROTUBULE BINDING 42 201 0.0001082 0.0007616
133 GROWTH FACTOR ACTIVITY 35 160 0.0001542 0.001077
134 RHO GTPASE BINDING 21 78 0.000162 0.001123
135 CADHERIN BINDING 11 28 0.0001653 0.001137
136 PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING 20 73 0.0001777 0.001214
137 DNA DEPENDENT ATPASE ACTIVITY 21 79 0.0001968 0.001335
138 GTPASE ACTIVITY 48 246 0.0002098 0.001412
139 HISTONE METHYLTRANSFERASE ACTIVITY 17 58 0.0002205 0.001473
140 RNA POLYMERASE II TRANSCRIPTION COFACTOR ACTIVITY 23 91 0.0002265 0.001503
141 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 14 43 0.0002325 0.001532
142 CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 12 34 0.0002759 0.001805
143 ATPASE BINDING 20 76 0.00032 0.002079
144 PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY 11 30 0.0003372 0.002161
145 NUCLEOSOMAL DNA BINDING 11 30 0.0003372 0.002161
146 STRUCTURAL CONSTITUENT OF CYTOSKELETON 24 100 0.0003863 0.002458
147 ESTROGEN RECEPTOR BINDING 13 40 0.0003938 0.002467
148 PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY 14 45 0.0003957 0.002467
149 SCAFFOLD PROTEIN BINDING 14 45 0.0003957 0.002467
150 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 10 26 0.0004013 0.002485
151 CYTOKINE RECEPTOR ACTIVITY 22 89 0.0004294 0.002642
152 GTPASE ACTIVATING PROTEIN BINDING 7 14 0.0004627 0.002828
153 FATTY ACID BINDING 11 31 0.0004682 0.002843
154 ATP DEPENDENT MICROTUBULE MOTOR ACTIVITY 8 18 0.0004891 0.002931
155 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 15 51 0.0004885 0.002931
156 RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 12 36 0.0005045 0.003005
157 DRUG BINDING 25 109 0.0006122 0.003608
158 SH3 SH2 ADAPTOR ACTIVITY 15 52 0.0006136 0.003608
159 HYDROLASE ACTIVITY ACTING ON ESTER BONDS 115 739 0.0006287 0.003673
160 STRUCTURAL MOLECULE ACTIVITY 114 732 0.0006435 0.003736
161 PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 8 19 0.0007591 0.004343
162 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 15 53 0.0007651 0.004343
163 PHOSPHOTYROSINE BINDING 7 15 0.0007808 0.004343
164 ENZYME INHIBITOR ACTIVITY 65 378 0.0007699 0.004343
165 PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 7 15 0.0007808 0.004343
166 LIGAND DEPENDENT NUCLEAR RECEPTOR TRANSCRIPTION COACTIVATOR ACTIVITY 15 53 0.0007651 0.004343
167 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 7 15 0.0007808 0.004343
168 POLY A RNA BINDING 171 1170 0.0007967 0.004406
169 PROTEIN DEACETYLASE ACTIVITY 13 43 0.0008574 0.004713
170 DNA SECONDARY STRUCTURE BINDING 9 24 0.0009701 0.005271
171 GAMMA TUBULIN BINDING 9 24 0.0009701 0.005271
172 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 12 39 0.001132 0.006077
173 RAC GTPASE BINDING 12 39 0.001132 0.006077
174 ATPASE ACTIVITY 71 427 0.001169 0.006241
175 TAU PROTEIN KINASE ACTIVITY 6 12 0.001212 0.006432
176 OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR 7 16 0.001249 0.006595
177 NUCLEOSOME BINDING 13 45 0.001371 0.007195
178 EPIDERMAL GROWTH FACTOR RECEPTOR BINDING 10 30 0.001468 0.007575
179 PROTEOGLYCAN BINDING 10 30 0.001468 0.007575
180 TUMOR NECROSIS FACTOR RECEPTOR BINDING 10 30 0.001468 0.007575
181 KINASE ACTIVATOR ACTIVITY 16 62 0.001538 0.007892
182 CHEMOKINE BINDING 8 21 0.001651 0.008383
183 G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING 8 21 0.001651 0.008383
184 SIGNALING ADAPTOR ACTIVITY 18 74 0.001679 0.008475
185 NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY 7 17 0.001912 0.009589
186 RNA POLYMERASE II TRANSCRIPTION COACTIVATOR ACTIVITY 11 36 0.00192 0.009589
NumGOOverlapSizeP ValueAdj. P Value
1 ANCHORING JUNCTION 164 489 1.55e-38 9.051e-36
2 CELL SUBSTRATE JUNCTION 144 398 3.801e-38 1.11e-35
3 SIDE OF MEMBRANE 136 428 2.286e-29 4.451e-27
4 CELL PROJECTION 363 1786 5.598e-29 8.173e-27
5 CELL JUNCTION 262 1151 2.229e-28 2.604e-26
6 CELL SURFACE 191 757 2.243e-26 1.871e-24
7 CELL LEADING EDGE 115 350 2.134e-26 1.871e-24
8 CYTOSKELETON 368 1967 2.187e-22 1.597e-20
9 CELL PROJECTION PART 207 946 2.639e-20 1.712e-18
10 MEMBRANE REGION 236 1134 4.202e-20 2.454e-18
11 MEMBRANE MICRODOMAIN 91 288 7.575e-20 4.022e-18
12 EXTRACELLULAR MATRIX 116 426 4.035e-19 1.964e-17
13 NEURON PROJECTION 202 942 8.654e-19 3.888e-17
14 EXTERNAL SIDE OF PLASMA MEMBRANE 78 238 3.086e-18 1.287e-16
15 TRANSCRIPTION FACTOR COMPLEX 89 298 1.108e-17 4.313e-16
16 NEURON PART 248 1265 1.263e-17 4.61e-16
17 PERINUCLEAR REGION OF CYTOPLASM 150 642 1.412e-17 4.85e-16
18 PROTEINACEOUS EXTRACELLULAR MATRIX 99 356 3.608e-17 1.171e-15
19 LAMELLIPODIUM 62 172 4.989e-17 1.534e-15
20 ACTIN CYTOSKELETON 111 444 1.897e-15 5.538e-14
21 CYTOPLASMIC SIDE OF MEMBRANE 59 170 2.1e-15 5.841e-14
22 CHROMOSOME 181 880 4.467e-15 1.186e-13
23 CYTOSKELETAL PART 263 1436 7.987e-15 2.028e-13
24 RUFFLE 55 156 8.644e-15 2.103e-13
25 NUCLEAR CHROMOSOME 121 523 4.46e-14 1.042e-12
26 PLASMA MEMBRANE REGION 184 929 1.063e-13 2.387e-12
27 EXTRACELLULAR SPACE 246 1376 9.943e-13 2.151e-11
28 INTRINSIC COMPONENT OF PLASMA MEMBRANE 284 1649 1.345e-12 2.805e-11
29 MICROTUBULE CYTOSKELETON 198 1068 7.521e-12 1.445e-10
30 CYTOPLASMIC REGION 75 287 7.176e-12 1.445e-10
31 SOMATODENDRITIC COMPARTMENT 135 650 7.67e-12 1.445e-10
32 INTRACELLULAR VESICLE 225 1259 1.071e-11 1.955e-10
33 CELL CORTEX 65 238 2.278e-11 4.031e-10
34 SPINDLE 73 289 7.595e-11 1.305e-09
35 SITE OF POLARIZED GROWTH 46 149 2.385e-10 3.98e-09
36 EXTRACELLULAR MATRIX COMPONENT 40 125 1.072e-09 1.738e-08
37 CELL BODY 103 494 1.941e-09 3.063e-08
38 CELL PROJECTION MEMBRANE 71 298 2.148e-09 3.302e-08
39 CELL CELL JUNCTION 85 383 2.382e-09 3.567e-08
40 CHROMATIN 94 441 3.093e-09 4.515e-08
41 GOLGI APPARATUS 239 1445 4.769e-09 6.792e-08
42 ACTIN FILAMENT 27 70 5.942e-09 8.263e-08
43 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 39 127 6.423e-09 8.723e-08
44 RUFFLE MEMBRANE 29 80 8.723e-09 1.158e-07
45 NUCLEAR CHROMATIN 68 291 1.082e-08 1.404e-07
46 METHYLTRANSFERASE COMPLEX 31 90 1.112e-08 1.412e-07
47 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 40 136 1.619e-08 2.012e-07
48 COMPLEX OF COLLAGEN TRIMERS 14 23 2.317e-08 2.819e-07
49 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 32 98 2.821e-08 3.363e-07
50 LEADING EDGE MEMBRANE 39 134 3.348e-08 3.91e-07
51 BASOLATERAL PLASMA MEMBRANE 53 211 3.555e-08 4.071e-07
52 CHROMOSOMAL REGION 73 330 3.639e-08 4.087e-07
53 EXTRINSIC COMPONENT OF MEMBRANE 60 252 3.799e-08 4.186e-07
54 MYELIN SHEATH 45 168 4.924e-08 5.325e-07
55 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 32 101 6.315e-08 6.705e-07
56 CELL CORTEX PART 35 119 1.25e-07 1.304e-06
57 SUPRAMOLECULAR FIBER 123 670 1.418e-07 1.453e-06
58 VACUOLE 195 1180 1.491e-07 1.501e-06
59 EXCITATORY SYNAPSE 49 197 1.591e-07 1.549e-06
60 AXON 85 418 1.582e-07 1.549e-06
61 DENDRITE 90 451 1.681e-07 1.609e-06
62 APICAL PART OF CELL 75 361 3.492e-07 3.289e-06
63 CHROMOSOME TELOMERIC REGION 42 162 3.595e-07 3.333e-06
64 POSTSYNAPSE 77 378 5.57e-07 5.083e-06
65 NUCLEOPLASM PART 126 708 5.723e-07 5.142e-06
66 BANDED COLLAGEN FIBRIL 9 12 6.027e-07 5.333e-06
67 MICROTUBULE 81 405 6.26e-07 5.457e-06
68 HISTONE METHYLTRANSFERASE COMPLEX 24 71 7.298e-07 6.268e-06
69 PRONUCLEUS 10 15 7.607e-07 6.346e-06
70 INTRINSIC COMPONENT OF THE CYTOPLASMIC SIDE OF THE PLASMA MEMBRANE 10 15 7.607e-07 6.346e-06
71 PLASMA MEMBRANE RAFT 27 86 8.106e-07 6.668e-06
72 NUCLEAR ENVELOPE 82 416 9.895e-07 8.026e-06
73 RECEPTOR COMPLEX 68 327 1.169e-06 9.352e-06
74 IMMUNOLOGICAL SYNAPSE 15 33 1.214e-06 9.578e-06
75 BASEMENT MEMBRANE 28 93 1.316e-06 1.011e-05
76 ACTIN BASED CELL PROJECTION 44 181 1.308e-06 1.011e-05
77 SARCOLEMMA 34 125 1.402e-06 1.063e-05
78 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 14 30 1.865e-06 1.396e-05
79 MICROTUBULE ORGANIZING CENTER 111 623 2.539e-06 1.877e-05
80 CORTICAL CYTOSKELETON 25 81 2.903e-06 2.12e-05
81 SYNAPSE 129 754 3.527e-06 2.512e-05
82 PLASMA MEMBRANE PROTEIN COMPLEX 94 510 3.509e-06 2.512e-05
83 SEMAPHORIN RECEPTOR COMPLEX 8 11 3.919e-06 2.757e-05
84 ENDOCYTIC VESICLE 55 256 4.316e-06 3.001e-05
85 NUCLEAR CHROMOSOME TELOMERIC REGION 34 132 5.267e-06 3.619e-05
86 GOLGI LUMEN 27 94 5.458e-06 3.706e-05
87 MAST CELL GRANULE 11 21 5.896e-06 3.957e-05
88 MICROTUBULE ASSOCIATED COMPLEX 36 145 6.988e-06 4.638e-05
89 MICROVILLUS 23 75 8.066e-06 5.293e-05
90 CATALYTIC COMPLEX 166 1038 9.383e-06 6.088e-05
91 NUCLEAR MATRIX 27 98 1.275e-05 8.184e-05
92 ACTIN FILAMENT BUNDLE 19 57 1.29e-05 8.189e-05
93 SYNAPSE PART 106 610 1.313e-05 8.243e-05
94 MIDBODY 33 132 1.419e-05 8.814e-05
95 LYSOSOMAL LUMEN 25 88 1.481e-05 8.915e-05
96 APICAL PLASMA MEMBRANE 59 292 1.455e-05 8.915e-05
97 NUCLEOLUS 139 848 1.468e-05 8.915e-05
98 MICROVILLUS MEMBRANE 10 19 1.504e-05 8.965e-05
99 FILOPODIUM 26 94 1.699e-05 0.0001002
100 ENDOPLASMIC RETICULUM LUMEN 44 201 2.324e-05 0.0001357
101 CENTROSOME 87 487 2.718e-05 0.0001556
102 FILAMENTOUS ACTIN 10 20 2.695e-05 0.0001556
103 PLATELET ALPHA GRANULE 22 75 2.745e-05 0.0001556
104 PLATELET ALPHA GRANULE LUMEN 18 55 2.876e-05 0.0001615
105 NEURON SPINE 30 121 4.044e-05 0.0002228
106 NUCLEAR PERIPHERY 30 121 4.044e-05 0.0002228
107 ACTOMYOSIN 19 62 4.895e-05 0.0002672
108 CONDENSED CHROMOSOME 42 195 5.247e-05 0.0002837
109 LYTIC VACUOLE 91 526 6.203e-05 0.0003324
110 SPINDLE MICROTUBULE 18 58 6.379e-05 0.0003387
111 CONTRACTILE FIBER 44 211 7.905e-05 0.0004159
112 PIGMENT GRANULE 26 103 9.329e-05 0.0004864
113 PLASMA MEMBRANE RECEPTOR COMPLEX 38 175 9.72e-05 0.0005023
114 ENDOSOME 127 793 9.827e-05 0.0005034
115 SWI SNF COMPLEX 8 15 9.924e-05 0.000504
116 KINESIN COMPLEX 17 55 0.000107 0.0005342
117 MITOTIC SPINDLE 17 55 0.000107 0.0005342
118 NPBAF COMPLEX 7 12 0.0001319 0.000653
119 MLL1 2 COMPLEX 11 28 0.0001653 0.0008111
120 SPINDLE POLE 29 126 0.0002202 0.001064
121 CORTICAL ACTIN CYTOSKELETON 17 58 0.0002205 0.001064
122 NUCLEAR MEMBRANE 53 280 0.0002253 0.001079
123 CHROMOSOME CENTROMERIC REGION 36 174 0.0003949 0.001875
124 SECRETORY VESICLE 78 461 0.0004065 0.001914
125 TRANSCRIPTION FACTOR TFTC COMPLEX 7 14 0.0004627 0.002162
126 HETEROCHROMATIN 18 67 0.0004774 0.002213
127 INTERCALATED DISC 15 51 0.0004885 0.002232
128 CONDENSED NUCLEAR CHROMOSOME CENTROMERIC REGION 8 18 0.0004891 0.002232
129 CONDENSED NUCLEAR CHROMOSOME 21 85 0.0005784 0.002619
130 VACUOLAR LUMEN 26 115 0.0006076 0.002729
131 NUCLEAR HETEROCHROMATIN 11 32 0.0006392 0.00285
132 PLATELET DENSE TUBULAR NETWORK 6 11 0.0006718 0.002972
133 PHAGOCYTIC VESICLE 21 86 0.0006828 0.002998
134 COSTAMERE 8 19 0.0007591 0.003309
135 NEURONAL POSTSYNAPTIC DENSITY 15 53 0.0007651 0.00331
136 CELL CELL CONTACT ZONE 17 64 0.0007812 0.003354
137 BASAL PLASMA MEMBRANE 11 33 0.0008591 0.003662
138 SECRETORY GRANULE 61 352 0.0009014 0.003814
139 VESICLE LUMEN 24 106 0.0009457 0.003973
140 AXONAL GROWTH CONE 8 20 0.001137 0.004744
141 INVADOPODIUM 6 12 0.001212 0.004948
142 CONDENSED CHROMOSOME OUTER KINETOCHORE 6 12 0.001212 0.004948
143 METHYLOSOME 6 12 0.001212 0.004948
144 BRUSH BORDER 23 102 0.001267 0.005126
145 LATERAL PLASMA MEMBRANE 14 50 0.001273 0.005126
146 T TUBULE 13 45 0.001371 0.005483
147 SECRETORY GRANULE LUMEN 20 85 0.001481 0.005883
148 REPLICATION FORK 16 62 0.001538 0.006067
149 U1 SNRNP 7 17 0.001912 0.007431
150 CELL DIVISION SITE 14 52 0.001921 0.007431
151 PSEUDOPODIUM 7 17 0.001912 0.007431
152 NUCLEAR BODY 59 349 0.001971 0.007572
153 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 43 237 0.001986 0.007582
154 COLLAGEN TRIMER 20 88 0.002307 0.00875
155 EARLY ENDOSOME MEMBRANE 24 113 0.002381 0.008969
156 AXON PART 40 219 0.002463 0.009219
157 SEX CHROMOSOME 9 27 0.002518 0.009306
158 SPINDLE MIDZONE 9 27 0.002518 0.009306
159 KINETOCHORE 25 120 0.002579 0.009474
160 SWI SNF SUPERFAMILY TYPE COMPLEX 17 71 0.002668 0.009738
161 FILOPODIUM MEMBRANE 7 18 0.002818 0.009991
162 PHAGOCYTIC CUP 7 18 0.002818 0.009991
163 CELL CELL ADHERENS JUNCTION 14 54 0.002823 0.009991
164 NEUROMUSCULAR JUNCTION 14 54 0.002823 0.009991
165 PERIKARYON 23 108 0.002796 0.009991

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04510_Focal_adhesion 97 200 1.589e-38 2.813e-36
2 hsa04810_Regulation_of_actin_cytoskeleton 85 214 3.307e-26 2.926e-24
3 hsa04110_Cell_cycle 60 128 2.455e-23 1.448e-21
4 hsa04360_Axon_guidance 57 130 1.765e-20 7.808e-19
5 hsa04062_Chemokine_signaling_pathway 67 189 7.511e-18 2.659e-16
6 hsa04722_Neurotrophin_signaling_pathway 52 127 3.077e-17 9.076e-16
7 hsa04660_T_cell_receptor_signaling_pathway 47 108 5.634e-17 1.425e-15
8 hsa04010_MAPK_signaling_pathway 81 268 1.516e-16 3.354e-15
9 hsa04662_B_cell_receptor_signaling_pathway 37 75 7.748e-16 1.524e-14
10 hsa04512_ECM.receptor_interaction 39 85 2.867e-15 5.074e-14
11 hsa04540_Gap_junction 40 90 4.871e-15 7.837e-14
12 hsa04380_Osteoclast_differentiation 48 128 2.915e-14 4.3e-13
13 hsa04914_Progesterone.mediated_oocyte_maturation 38 87 4.648e-14 6.328e-13
14 hsa04912_GnRH_signaling_pathway 41 101 9.652e-14 1.22e-12
15 hsa04670_Leukocyte_transendothelial_migration 44 117 3.043e-13 3.59e-12
16 hsa04666_Fc_gamma_R.mediated_phagocytosis 38 95 1.33e-12 1.472e-11
17 hsa04664_Fc_epsilon_RI_signaling_pathway 34 79 1.669e-12 1.738e-11
18 hsa04370_VEGF_signaling_pathway 33 76 2.62e-12 2.577e-11
19 hsa04012_ErbB_signaling_pathway 35 87 8.351e-12 7.396e-11
20 hsa04310_Wnt_signaling_pathway 49 151 8.357e-12 7.396e-11
21 hsa04114_Oocyte_meiosis 41 114 1.045e-11 8.804e-11
22 hsa04144_Endocytosis 59 203 1.198e-11 9.486e-11
23 hsa04640_Hematopoietic_cell_lineage 35 88 1.233e-11 9.486e-11
24 hsa04350_TGF.beta_signaling_pathway 32 85 4.932e-10 3.638e-09
25 hsa04916_Melanogenesis 34 101 4.339e-09 3.072e-08
26 hsa04620_Toll.like_receptor_signaling_pathway 34 102 5.788e-09 3.94e-08
27 hsa04630_Jak.STAT_signaling_pathway 44 155 1.048e-08 6.868e-08
28 hsa04270_Vascular_smooth_muscle_contraction 36 116 1.782e-08 1.127e-07
29 hsa04520_Adherens_junction 26 73 7.681e-08 4.688e-07
30 hsa04910_Insulin_signaling_pathway 39 138 8.035e-08 4.741e-07
31 hsa04621_NOD.like_receptor_signaling_pathway 22 59 3.02e-07 1.724e-06
32 hsa04115_p53_signaling_pathway 24 69 4.004e-07 2.215e-06
33 hsa04650_Natural_killer_cell_mediated_cytotoxicity 37 136 4.87e-07 2.612e-06
34 hsa04974_Protein_digestion_and_absorption 26 81 7.998e-07 4.164e-06
35 hsa04720_Long.term_potentiation 23 70 2.165e-06 1.095e-05
36 hsa04330_Notch_signaling_pathway 18 47 2.276e-06 1.119e-05
37 hsa04145_Phagosome 39 156 2.463e-06 1.178e-05
38 hsa04971_Gastric_acid_secretion 23 74 6.277e-06 2.924e-05
39 hsa04320_Dorso.ventral_axis_formation 12 25 7.128e-06 3.235e-05
40 hsa04730_Long.term_depression 22 70 8.118e-06 3.592e-05
41 hsa04150_mTOR_signaling_pathway 18 52 1.2e-05 5.179e-05
42 hsa04972_Pancreatic_secretion 27 101 2.315e-05 9.756e-05
43 hsa04070_Phosphatidylinositol_signaling_system 22 78 5.334e-05 0.0002196
44 hsa04970_Salivary_secretion 24 89 5.54e-05 0.0002228
45 hsa04514_Cell_adhesion_molecules_.CAMs. 31 136 0.0001641 0.0006456
46 hsa04020_Calcium_signaling_pathway 37 177 0.0002673 0.001028
47 hsa00230_Purine_metabolism 34 162 0.0004293 0.001583
48 hsa04210_Apoptosis 22 89 0.0004294 0.001583
49 hsa04340_Hedgehog_signaling_pathway 16 56 0.0004599 0.001661
50 hsa04960_Aldosterone.regulated_sodium_reabsorption 13 42 0.0006685 0.002366
51 hsa04962_Vasopressin.regulated_water_reabsorption 13 44 0.001089 0.003707
52 hsa04973_Carbohydrate_digestion_and_absorption 13 44 0.001089 0.003707
53 hsa04530_Tight_junction 28 133 0.001255 0.00419
54 hsa04672_Intestinal_immune_network_for_IgA_production 13 49 0.003168 0.01038
55 hsa03440_Homologous_recombination 9 28 0.003333 0.01073
56 hsa03030_DNA_replication 10 36 0.006488 0.02051
57 hsa00562_Inositol_phosphate_metabolism 13 57 0.01226 0.03808
58 hsa03410_Base_excision_repair 9 34 0.01335 0.04073
59 hsa04976_Bile_secretion 15 71 0.01513 0.04539
60 hsa04612_Antigen_processing_and_presentation 16 78 0.01627 0.048
61 hsa04120_Ubiquitin_mediated_proteolysis 25 139 0.01733 0.0503
62 hsa03010_Ribosome 18 92 0.01804 0.05149
63 hsa00051_Fructose_and_mannose_metabolism 9 36 0.01939 0.05446
64 hsa00430_Taurine_and_hypotaurine_metabolism 4 10 0.02143 0.05928
65 hsa00290_Valine._leucine_and_isoleucine_biosynthesis 4 11 0.03064 0.08307
66 hsa00052_Galactose_metabolism 7 27 0.03098 0.08307
67 hsa00010_Glycolysis_._Gluconeogenesis 13 65 0.03444 0.091
68 hsa00590_Arachidonic_acid_metabolism 12 59 0.03664 0.09536
69 hsa00670_One_carbon_pool_by_folate 5 18 0.04957 0.1271
70 hsa00270_Cysteine_and_methionine_metabolism 8 36 0.05098 0.1289
71 hsa00480_Glutathione_metabolism 10 50 0.05908 0.1473
72 hsa04622_RIG.I.like_receptor_signaling_pathway 13 71 0.06385 0.157
73 hsa00603_Glycosphingolipid_biosynthesis_._globo_series 4 14 0.07017 0.1701
74 hsa03420_Nucleotide_excision_repair 9 45 0.07114 0.1702
75 hsa00030_Pentose_phosphate_pathway 6 27 0.08538 0.2015
76 hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism 9 48 0.09877 0.23
77 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 5 22 0.1037 0.2383
78 hsa04260_Cardiac_muscle_contraction 13 77 0.1064 0.2415
79 hsa04744_Phototransduction 6 29 0.1126 0.2523
80 hsa04130_SNARE_interactions_in_vesicular_transport 7 36 0.1174 0.2538
81 hsa00910_Nitrogen_metabolism 5 23 0.1204 0.2538
82 hsa03430_Mismatch_repair 5 23 0.1204 0.2538
83 hsa04710_Circadian_rhythm_._mammal 5 23 0.1204 0.2538
84 hsa04964_Proximal_tubule_bicarbonate_reclamation 5 23 0.1204 0.2538
85 hsa00740_Riboflavin_metabolism 3 11 0.127 0.2645
86 hsa00310_Lysine_degradation 8 44 0.1321 0.2719
87 hsa03040_Spliceosome 19 128 0.1574 0.3203
88 hsa00250_Alanine._aspartate_and_glutamate_metabolism 6 32 0.1605 0.3206
89 hsa04920_Adipocytokine_signaling_pathway 11 68 0.1612 0.3206
90 hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate 5 26 0.1774 0.3489
91 hsa00920_Sulfur_metabolism 3 13 0.1855 0.3608
92 hsa00460_Cyanoamino_acid_metabolism 2 7 0.1912 0.3678
93 hsa04141_Protein_processing_in_endoplasmic_reticulum 23 168 0.2312 0.44
94 hsa02010_ABC_transporters 7 44 0.2457 0.4626
95 hsa00240_Pyrimidine_metabolism 14 99 0.2573 0.4794
96 hsa00020_Citrate_cycle_.TCA_cycle. 5 30 0.2654 0.4893
97 hsa00770_Pantothenate_and_CoA_biosynthesis 3 16 0.2825 0.5154
98 hsa00140_Steroid_hormone_biosynthesis 8 57 0.3415 0.6168
99 hsa00565_Ether_lipid_metabolism 5 36 0.409 0.7238
100 hsa03320_PPAR_signaling_pathway 9 70 0.4272 0.7486
101 hsa03022_Basal_transcription_factors 5 37 0.4329 0.7495
102 hsa00330_Arginine_and_proline_metabolism 7 54 0.4404 0.7495
103 hsa00500_Starch_and_sucrose_metabolism 7 54 0.4404 0.7495
104 hsa00564_Glycerophospholipid_metabolism 10 80 0.4539 0.7651
105 hsa04623_Cytosolic_DNA.sensing_pathway 7 56 0.4796 0.7933
106 hsa03450_Non.homologous_end.joining 2 14 0.4961 0.8099
107 hsa00600_Sphingolipid_metabolism 5 40 0.5033 0.8099
108 hsa00620_Pyruvate_metabolism 5 40 0.5033 0.8099
109 hsa00640_Propanoate_metabolism 4 32 0.519 0.8277
110 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 2 15 0.5341 0.844
111 hsa00760_Nicotinate_and_nicotinamide_metabolism 3 24 0.5397 0.8453
112 hsa04610_Complement_and_coagulation_cascades 8 69 0.5586 0.8673
113 hsa00360_Phenylalanine_metabolism 2 17 0.6039 0.929
114 hsa00970_Aminoacyl.tRNA_biosynthesis 7 63 0.6088 0.929
115 hsa00650_Butanoate_metabolism 3 30 0.6938 1
116 hsa03013_RNA_transport 16 152 0.7007 1
117 hsa03018_RNA_degradation 7 71 0.7326 1
118 hsa04742_Taste_transduction 5 52 0.7376 1
119 hsa03008_Ribosome_biogenesis_in_eukaryotes 8 81 0.7385 1
120 hsa00410_beta.Alanine_metabolism 2 22 0.7431 1
121 hsa00280_Valine._leucine_and_isoleucine_degradation 4 44 0.7681 1
122 hsa04977_Vitamin_digestion_and_absorption 2 24 0.7858 1
123 hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series 2 26 0.8222 1
124 hsa00510_N.Glycan_biosynthesis 4 49 0.8366 1
125 hsa04966_Collecting_duct_acid_secretion 2 27 0.8382 1
126 hsa00561_Glycerolipid_metabolism 4 50 0.848 1
127 hsa03015_mRNA_surveillance_pathway 7 83 0.8623 1
128 hsa03020_RNA_polymerase 2 29 0.8663 1
129 hsa00830_Retinol_metabolism 5 64 0.8792 1
130 hsa00380_Tryptophan_metabolism 3 42 0.8808 1
131 hsa00860_Porphyrin_and_chlorophyll_metabolism 3 43 0.8904 1
132 hsa00040_Pentose_and_glucuronate_interconversions 2 32 0.9002 1
133 hsa04142_Lysosome 10 121 0.9081 1
134 hsa00514_Other_types_of_O.glycan_biosynthesis 3 46 0.9153 1
135 hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 5 71 0.9268 1
136 hsa00983_Drug_metabolism_._other_enzymes 3 52 0.9503 1
137 hsa00350_Tyrosine_metabolism 2 41 0.9598 1
138 hsa03050_Proteasome 2 45 0.9735 1
139 hsa00982_Drug_metabolism_._cytochrome_P450 3 73 0.9933 1
140 hsa00190_Oxidative_phosphorylation 7 132 0.9959 1
141 hsa04146_Peroxisome 2 79 0.9994 1
142 hsa04740_Olfactory_transduction 7 388 1 1

Quest ID: c16b4adea4b56fff8f146e0b42f41ff2